var title_f7_51_7984="Contents: Laboratory medicine";
var content_f7_51_7984=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?1/34/1568\">",
"       Family Medicine and General Practice",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Laboratory medicine",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Laboratory medicine",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Adrenal tests",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/35/7736\">",
"           Assays of the renin-angiotensin-aldosterone system in adrenal disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/46/44777\">",
"           Diagnosis of adrenal insufficiency in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/25/21913\">",
"           Establishing the diagnosis of Cushing's syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/19/40246\">",
"           Measurement of ACTH, CRH, and other hypothalamic and pituitary peptides",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/8/132\">",
"           Measurement of cortisol in serum and saliva",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/22/41319\">",
"           Measurement of urinary excretion of endogenous and exogenous glucocorticoids",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Autoantibody tests",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/43/2743\">",
"           Anti-U1 RNP antibodies in mixed connective tissue disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/10/1192\">",
"           Antibodies to double-stranded (ds)DNA, Sm, and U1 RNP",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/4/27718\">",
"           Antiribosomal P protein antibodies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/28/9674\">",
"           Clinical spectrum of antineutrophil cytoplasmic antibodies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/23/3447\">",
"           Definition and diagnosis of mixed connective tissue disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/29/27096\">",
"           Diagnosis of the antiphospholipid syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/54/28520\">",
"           Measurement and clinical significance of antinuclear antibodies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/44/42695\">",
"           Miscellaneous antinuclear antibodies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/41/42648\">",
"           Origin and utility of measurement of rheumatoid factors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/34/29224\">",
"           Overview of the clinical manifestations of systemic sclerosis (scleroderma) in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/23/8568\">",
"           The anti-Ro/SSA and anti-La/SSB antigen-antibody systems",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Fluid and electrolyte tests",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/44/31432\">",
"           Approach to the adult with metabolic acidosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/13/5338\">",
"           Approach to the patient with hypertension and hypokalemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/35/39479\">",
"           Clinical manifestations and evaluation of metabolic alkalosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/7/2167\">",
"           Diagnosis and treatment of hypophosphatemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/28/20934\">",
"           Diagnostic approach to hypercalcemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/13/34005\">",
"           Diagnostic approach to hypocalcemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/63/11254\">",
"           Evaluation and treatment of hypomagnesemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/9/9366\">",
"           Evaluation of the patient with hypokalemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/20/21832\">",
"           Evaluation of the patient with hyponatremia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/13/13527\">",
"           Overview of the causes and treatment of hyperphosphatemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/29/470\">",
"           Regulation of magnesium balance",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/8/23685\">",
"           Relation between total and ionized serum calcium concentration",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/43/36533\">",
"           Serum anion gap in conditions other than metabolic acidosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/29/41430\">",
"           Serum osmolal gap",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/41/27288\">",
"           Simple and mixed acid-base disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/1/21526\">",
"           The ������anion gap/������HCO3 ratio in patients with a high anion gap metabolic acidosis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hematology tests",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/3/5178\">",
"           Approach to the adult patient with a bleeding diathesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/46/29418\">",
"           Approach to the adult patient with anemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/19/15674\">",
"           Approach to the adult patient with thrombocytopenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/3/18489\">",
"           Approach to the diagnosis of hemolytic anemia in the adult",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/10/24745\">",
"           Approach to the patient with eosinophilia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/52/29511\">",
"           Approach to the patient with neutrophilia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/6/24681\">",
"           Approach to the patient with thrombocytosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/54/35690\">",
"           Automated hematology instrumentation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/22/5482\">",
"           Bone marrow aspiration and biopsy: Indications and technique",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/39/26234\">",
"           Causes and diagnosis of anemia due to iron deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/6/20586\">",
"           Clinical and laboratory aspects of platelet transfusion therapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/60/4041\">",
"           Clinical course and management of monoclonal gammopathy of undetermined significance",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/51/19256\">",
"           Clinical features and diagnosis of autoimmune hemolytic anemia: Warm agglutinins",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/56/33672\">",
"           Clinical features and treatment of autoimmune hemolytic anemia: Cold agglutinins",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/13/30938\">",
"           Clinical manifestations and diagnosis of immune thrombocytopenia (ITP) in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/36/4682\">",
"           Clinical use of coagulation tests",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/0/5130\">",
"           Diagnosis and treatment of vitamin B12 and folate deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/59/15290\">",
"           Diagnosis of monoclonal gammopathy of undetermined significance",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/54/42856\">",
"           Diagnosis of sickle cell syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/12/24777\">",
"           Diagnostic approach to the patient with polycythemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/32/9738\">",
"           Diagnostic approach to the patient with suspected polycythemia vera",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/23/13689\">",
"           Evaluation of bone marrow aspirate smears",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/26/38313\">",
"           Evaluation of the peripheral blood smear",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/45/35543\">",
"           Mean corpuscular volume",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/47/18170\">",
"           Overview of neutropenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/19/35129\">",
"           Pathophysiology and diagnosis of iron overload syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/59/23482\">",
"           Platelet function testing",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/26/24999\">",
"           Prenatal testing for the hemoglobinopathies and thalassemias",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/58/10154\">",
"           Recognition of monoclonal proteins",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Liver function tests",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/18/34090\">",
"           Approach to the patient with abnormal liver biochemical and function tests",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/28/36294\">",
"           Clinical aspects of serum bilirubin determination",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/50/42790\">",
"           Diagnostic approach to the patient with jaundice or asymptomatic hyperbilirubinemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/57/19353\">",
"           Enzymatic measures of cholestasis (eg, alkaline phosphatase, 5���������-nucleotidase, gamma-glutamyl transpeptidase)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/63/21494\">",
"           Liver biochemical tests that detect injury to hepatocytes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/20/5446\">",
"           Patterns of plasma aspartate and alanine aminotransferase levels with and without liver disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/29/24022\">",
"           Tests of the liver's biosynthetic capacity (eg, albumin, coagulation factors, prothrombin time)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/22/22889\">",
"           Tests of the liver's capacity to transport organic anions and metabolize drugs",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Miscellaneous",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/42/38569\">",
"           Acute phase reactants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/15/40185\">",
"           Cervical cytology: Interpretation of results",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/11/28857\">",
"           General principles in the use of immune globulin",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/49/17175\">",
"           Intravenous immune globulin in hematologic disorders",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pancreas function tests",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/27/10679\">",
"           Approach to the patient with elevated serum amylase or lipase",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/21/38232\">",
"           Clinical features and diagnosis of malabsorption",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pulmonary function tests",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/33/15894\">",
"           Arterial blood gases",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/14/7400\">",
"           Diffusing capacity for carbon monoxide",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/53/4952\">",
"           Overview of pulmonary function testing in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/8/33925\">",
"           Oxygenation and mechanisms of hypoxemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/32/9736\">",
"           Pulse oximetry",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/59/9141\">",
"           Reference values for pulmonary function testing",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/41/27288\">",
"           Simple and mixed acid-base disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/35/13877\">",
"           Venous blood gases and other alternatives to arterial blood gases",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Renal function tests",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/45/36570\">",
"           Assessment of kidney function",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/37/13914\">",
"           Assessment of urinary protein excretion and evaluation of isolated non-nephrotic proteinuria in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/23/35190\">",
"           Calculation of the creatinine clearance",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/57/41875\">",
"           Drugs that elevate the serum creatinine concentration",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/54/12138\">",
"           Etiology and diagnosis of prerenal disease and acute tubular necrosis in acute kidney injury (acute renal failure)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/17/8472\">",
"           Fractional excretion of sodium, urea, and other molecules in acute kidney injury (acute renal failure)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/1/34839\">",
"           Investigational biomarkers and the evaluation of acute tubular necrosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/15/17655\">",
"           Orthostatic (postural) proteinuria",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/39/34418\">",
"           The significance of urinary eosinophils",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/34/22058\">",
"           Urinalysis in the diagnosis of kidney disease",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Tests for infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/14/11494\">",
"           Blood cultures for the detection of bacteremia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/15/35059\">",
"           Microbiology specimen collection and transport",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/11/17591\">",
"           Sputum cultures for the evaluation of bacterial pneumonia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/41/24214\">",
"           Urine sampling and culture in the diagnosis of urinary tract infection in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Tests of immune system",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/38/24167\">",
"           Human leukocyte antigens (HLA): A roadmap",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/58/43945\">",
"           Laboratory evaluation of the immune system",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/25/10647\">",
"           Overview and clinical assessment of the complement system",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/51/12090\">",
"           Pathogenesis of spondyloarthritis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Thyroid function tests",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/7/26744\">",
"           Diagnosis of and screening for hypothyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/57/26520\">",
"           Diagnosis of hyperthyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/40/42632\">",
"           Drug interactions with thyroid hormones",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/53/856\">",
"           Euthyroid hyperthyroxinemia and hypothyroxinemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/33/3608\">",
"           Laboratory assessment of thyroid function",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Transfusion medicine",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/22/2407\">",
"           Compatibility testing",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/18/4393\">",
"           Granulocyte transfusions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/41/40601\">",
"           Laboratory testing of donated blood",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/53/27480\">",
"           The incompatible crossmatch",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/37/21081\">",
"           Use of red blood cells for transfusion",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-5F96ADFB61-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f7_51_7984=[""].join("\n");
var outline_f7_51_7984=null;
var title_f7_51_7985="Secnidazole: International drug information";
var content_f7_51_7985=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Secnidazole: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F4303344\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Flagentyl (AR, FR);",
"     </li>",
"     <li>",
"      Minovag (MX);",
"     </li>",
"     <li>",
"      Sabima (MX);",
"     </li>",
"     <li>",
"      Secni (BR);",
"     </li>",
"     <li>",
"      Secnidal (BR, MX);",
"     </li>",
"     <li>",
"      Secnil (IN);",
"     </li>",
"     <li>",
"      Sindil (CO);",
"     </li>",
"     <li>",
"      Skorpy (CO)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1980181\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antibiotic, Miscellaneous",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antiprotozoal",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F1980184\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of parasitic infections, including amebiasis, giardiasis, and",
"     <i>",
"      Trichomonas vaginalis",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F1980180\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults: Oral: 2 g single dose; tablets may be given with food to avoid gastrointestinal intolerance",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821149\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F1980183\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet: 500 mg",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10434 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-122.72.76.133-D3B5B19E3F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_51_7985=[""].join("\n");
var outline_f7_51_7985=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4303344\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1980181\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1980184\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1980180\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821149\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1980183\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10434\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10434|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_51_7986="Unstable metacarpal neck fracture";
var content_f7_51_7986=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F74472&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F74472&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Unstable metacarpal neck fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 442px; height: 334px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Unstable metacarpal neck fractures can be treated by closed reduction and percutaneously inserted K-wires.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_51_7986=[""].join("\n");
var outline_f7_51_7986=null;
var title_f7_51_7987="Lightwand placement";
var content_f7_51_7987=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F74936&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F74936&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Lightwand placement",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The transillumination of the lighted stylet appears as a focused glow in the thyroid cartilage, indicating that the lightwand assembly is in the trachea.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Murphy MF, Hung OR. Lighted stylet intubation. In: Walls RM, Murphy MF (eds). Manual of Emergency Airway Management, 3rd edition. Lippincott Williams &amp; Wilkins, Philadelphia, 2008. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_51_7987=[""].join("\n");
var outline_f7_51_7987=null;
var title_f7_51_7988="Base of the first metacarpal fracture types";
var content_f7_51_7988=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F57258&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F57258&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Base of the first metacarpal fracture types",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 445px; height: 424px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Type I (Bennet's fracture-dislocation) and type II (Rolando's fracture) are intraarticular. Type III fractures are extraarticular, either transverse (IIIA) or oblique (IIIB). Type IV fractures are seen only in children and involve the proximal epiphysis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Eiff MP, Hatch RL, Calmbach WL. Fracture Management for Primary Care, 2nd ed., W.B. Saunders 2002. Copyright &copy; 2002 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_51_7988=[""].join("\n");
var outline_f7_51_7988=null;
var title_f7_51_7989="Mucinous carcinoma of the breast";
var content_f7_51_7989=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F79319&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F79319&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 607px\">",
"   <div class=\"ttl\">",
"    Mucinous carcinoma of the breast",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 587px; height: 237px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (Panel A) Low power view of a mucinous breast carcinomashows small nests of tumor cells dispersed in large pools of extracellular mucous.",
"    <br/>",
"    (Panel B) High power view demonstrates that the nests are composed of cells with relatively uniform, low grade nuclei.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Stuart Schnitt, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_51_7989=[""].join("\n");
var outline_f7_51_7989=null;
var title_f7_51_7990="Crusted scabies hand";
var content_f7_51_7990=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F82371&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F82371&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Crusted scabies",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 264px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Crusted scabies in a patient with acquired immunodeficiency syndrome. Note the crusted papules and the white linear burrows.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy;2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_51_7990=[""].join("\n");
var outline_f7_51_7990=null;
var title_f7_51_7991="Brain MRI postpartum angiopathy";
var content_f7_51_7991=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F77149&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F77149&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 545px\">",
"   <div class=\"ttl\">",
"    Brain MRI of a 33 year old woman with postpartum angiopathy (reversible cerebral vasoconstriction syndrome)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 525px; height: 335px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Head MRI axial cuts: Fluid-attenuated inversion recovery (FLAIR) (A, B, E, F) and apparent diffusion coefficient map (C, D, G, H) sequences.",
"    <br>",
"     Upper panel MRI, performed on admission, showed FLAIR hyperintensities and diffusion restriction in the right parietal lobe and in the splenium of the corpus callosum (arrows). Lower panel, done on hospital day 3 when the patient deteriorated, showed worsening bilateral&nbsp;lesions involving the cortex and subcortical white matter of the parietal, posterior frontal, and occipital lobes (arrows).",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"      Reproduced with permission from: Maalouf N, Harik SI. Clinical reasoning: A 33-year-old woman with severe postpartum occipital headaches. Neurology 2012; 78:366. Copyright &copy; 2012 Lippincott Williams &amp; Wilkins.",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_51_7991=[""].join("\n");
var outline_f7_51_7991=null;
var title_f7_51_7992="Cartilage-hair hypoplasia";
var content_f7_51_7992=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"15\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Cartilage-hair hypoplasia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/51/7992/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/51/7992/contributors\">",
"     Nicholas L Rider, DO",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/51/7992/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/51/7992/contributors\">",
"     E Richard Stiehm, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/51/7992/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/51/7992/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?7/51/7992/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 28, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cartilage-hair hypoplasia (CHH; MIM 250250) is a skeletal dysplasia inherited as an autosomal recessive trait. CHH is sometimes also referred to as immunodeficiency with short limbed dwarfism. It is caused by mutations in the ribonuclease mitochondrial RNA-processing (RMRP) gene [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/1\">",
"     1",
"    </a>",
"    ]. Common features of the disorder include short stature, fine sparse hair, varying degrees of immune deficiency, Hirschsprung disease, and a susceptibility to hematologic malignancies [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Individuals with CHH have normal intelligence and achieve normal developmental milestones throughout childhood.",
"   </p>",
"   <p>",
"    CHH is diagnosed clinically by observing fine and often sparse hair in an individual with short stature with disproportionally short limbs. Genetic analysis of the RMRP gene confirms the diagnosis. Immune-related complications (immunodeficiency, malignancy, and autoimmune disease) lead many to medical attention early in life, and are a major cause of early mortality.",
"   </p>",
"   <p>",
"    This topic will review the pathogenesis, clinical manifestations, diagnosis, and management of CHH. Other syndromic immunodeficiencies are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/22/40295?source=see_link\">",
"     \"Syndromic immunodeficiencies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;CHH is a rare disorder in the general population, but exists with greater prevalence among the Old Order Amish and Finnish populations [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/4\">",
"     4",
"    </a>",
"    ]. Thus, any person with short stature and immune deficiency with Amish or Finnish inheritance should be evaluated for CHH.",
"   </p>",
"   <p>",
"    One Finnish study estimated an incidence of 1:23,000 [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/5\">",
"     5",
"    </a>",
"    ]. The carrier frequency of a point mutation in the ribonuclease mitochondrial RNA-processing gene (RMRP 70 A&gt;G) is estimated to be as high as 1 in 19 among the Old Order Amish [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The Old Order Amish are members of a larger Anabaptist group which also included the Old Order Mennonites [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/6\">",
"     6",
"    </a>",
"    ]. The Anabaptists fled religious persecution in Europe and eventually immigrated to America in the late 1600s. Members of the Old Order Amish sect are widely distributed throughout the United States, but approximately 70 percent are concentrated in four counties: Lancaster County, Pennsylvania; Holmes and Geauga Counties of Ohio; and LaGrange County, Indiana.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     GENETICS AND PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;CHH is an autosomal recessive disorder caused by mutations in the ribonuclease mitochondrial RNA-processing (RMRP) gene [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/1,7\">",
"     1,7",
"    </a>",
"    ]. This gene encodes for the untranslated RNA component of a mitochondrial RNA-processing endonuclease (RNase mitochondrial RNA processing [MRP]), a protein-RNA complex that plays a role in nucleolar processing of ribosomal RNA (rRNA), cleavage of mitochondrial RNA (mRNA) in mitochondrial DNA synthesis, and cleavage of cyclin B2 mRNA in cell cycle control.",
"   </p>",
"   <p>",
"    The RMRP 70 A&gt;G mutation occurs in 30 to 48 percent of patients with CHH, but is more common in the genetically isolated Amish and Finnish populations [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/1,4,8-10\">",
"     1,4,8-10",
"    </a>",
"    ]. Numerous other mutations in the RMRP promoter region and gene have been identified in patients with CHH.",
"   </p>",
"   <p>",
"    Phenotypic heterogeneity is great, even among patients homozygous for the RMRP 70 A&gt;G mutation [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/3,7,11,12\">",
"     3,7,11,12",
"    </a>",
"    ]. RMRP mutations that reduce rRNA cleavage are associated with bone dysplasia, whereas defects that decrease mRNA cleavage are associated with hair hypoplasia, immunodeficiency, and hematologic abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/13\">",
"     13",
"    </a>",
"    ]. The degree of reduced rRNA or mRNA cleavage correlates with the degree of phenotypic severity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;CHH is a diverse disorder with varied clinical manifestations. Originally thought to be achondroplasia, CHH was first described as a distinct clinical entity among the Old Order Amish of Pennsylvania by Victor McKusick [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Somatic growth and musculoskeletal findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;The musculoskeletal system is most consistently affected in CHH. Short stature and short limbs with increased carrying angle at the elbow are universally found in persons with CHH (",
"    <a class=\"graphic graphic_picture graphicRef77453 \" href=\"UTD.htm?2/54/2914\">",
"     picture 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef63666 \" href=\"UTD.htm?8/2/8224\">",
"     picture 2",
"    </a>",
"    ). Increased lumbar lordosis, ligamentous laxity, and scoliosis are common and age dependent [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/2,14,15\">",
"     2,14,15",
"    </a>",
"    ]. Metaphyseal dysplasia, with scalloped, flared, and sclerotic metaphyses, most frequently affects the lower extremities. The degree of metaphyseal abnormality correlates with growth velocity and final height [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One detailed radiographic study of 82 patients with CHH showed that long bone growth was particularly abnormal and progressive in CHH [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/16\">",
"     16",
"    </a>",
"    ]. In the same study, scoliosis was noted in 25 percent of patients overall and in 44 percent of adults [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/16\">",
"     16",
"    </a>",
"    ]. Another series of 100 patients with CHH showed that relative limb growth rates declined rapidly in early childhood and the pubertal growth spurt was minimal to absent [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/17\">",
"     17",
"    </a>",
"    ]. Appendicular skeletal growth was particularly abnormal, but axial skeletal dimensions were also affected among persons with CHH, indicating the global dysfunction of skeletal growth in this syndrome.",
"   </p>",
"   <p>",
"    Analysis of the Finnish and Amish (unpublished observation) CHH cohorts showed that most individuals were short at birth, but of normal weight for gestational age [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/15\">",
"     15",
"    </a>",
"    ]. Median adult heights were 131 cm (51.6 in) and 122.5 cm (48.2 in) for males and females, respectively in the Finnish cohort [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Growth velocity is generally normal for weight and length. However, most persons with CHH do not plot along \"normal\" percentiles. Head circumference is an exception, in that normal measurements and growth velocity are the rule. Head measurements below the third percentile, or those that do not follow a normal growth percentile, should prompt further evaluations in a person with CHH. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/51/36665?source=see_link&amp;anchor=H16#H16\">",
"     \"Etiology and evaluation of microcephaly in infants and children\", section on 'Evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Many individuals with CHH suffer arthralgias and progressive arthritis due to the metaphyseal abnormalities intrinsic to the disorder. However, the degree of metaphyseal abnormality does not appear to correlate with severity of symptomatic joint disease [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/16\">",
"     16",
"    </a>",
"    ]. Some individuals benefit from joint replacement surgery or arthroscopy, although a comprehensive analysis of these interventions and their benefit for CHH is lacking.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Gastrointestinal abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastrointestinal anomalies in CHH range from classic Hirschsprung disease (HD), to long-segment disease, to total colonic aganglionosis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/19\">",
"     19",
"    </a>",
"    ]. Enterocolitis is commonly associated with HD in the setting of CHH. It is a potentially lethal complication due to the severity of the inflammation and the risk of bacterial translocation into the bloodstream with subsequent sepsis in an individual with immunodeficiency. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Immunodeficiency'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41848?source=see_link\">",
"     \"Congenital aganglionic megacolon (Hirschsprung disease)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Hair abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormal hair morphology is a hallmark of the CHH phenotype. Hair is fine, but may vary in texture from patient to patient and even appear normal on gross inspection. However, hair shaft diameter in CHH is 50 to 67 percent smaller than normal hair when viewed under magnification [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/20\">",
"     20",
"    </a>",
"    ]. CHH hair is more fragile than normal hair and weaker when subjected to tensile strength testing [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/21\">",
"     21",
"    </a>",
"    ]. However, amino acid analysis reveals no difference in sulphur-containing amino acid composition compared to controls (disulfide bonds and sulfhydryl groups are major components of keratin in hair).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Immunodeficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Impairment of immune function is the greatest health risk among persons with CHH and represents the most common cause of premature death in this syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/22\">",
"     22",
"    </a>",
"    ]. ALL persons with CHH are at risk for severe, frequent, and unusual infections irrespective of their laboratory findings.",
"   </p>",
"   <p>",
"    Various host-defense abnormalities are described in persons with CHH [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/3,15,23-29\">",
"     3,15,23-29",
"    </a>",
"    ]. Cell-mediated immunodeficiency (combined immunodeficiency) is most commonly reported. In a series of 108 patients with CHH from Finland, 88 percent of patients had in vitro evidence of abnormal cellular immunity [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/15\">",
"     15",
"    </a>",
"    ]. More than one-half had an increased susceptibility to infection, and 6 percent died of primary infections. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/58/40873?source=see_link\">",
"     \"Combined immunodeficiencies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Fatal varicella infection has been described in a number of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/2\">",
"     2",
"    </a>",
"    ]. However many individuals from the Amish cohort have developed native immunity to varicella without serious sequelae. Patients may develop infections with organisms that signify a severe T cell defect, such a Pneumocystis carinii (P. jirovecii) pneumonia, cytomegalovirus pneumonitis, or severe oropharyngeal candidiasis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Severe combined immunodeficiency (SCID) is known to occur in the setting of CHH [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/30-33\">",
"     30-33",
"    </a>",
"    ]. SCID may present in classic fashion with alymphocytosis and severe humoral defects, with severe T and B cell functional defects, but quantifiable cell counts, or with an Omenn syndrome phenotype [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/3,7,30\">",
"     3,7,30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/30/42471?source=see_link\">",
"     \"Severe combined immunodeficiency (SCID): An overview\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/0/10?source=see_link\">",
"     \"Severe combined immunodeficiency (SCID): Specific defects\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Sinopulmonary infections suggestive of humoral immune deficiency are also common in CHH. In the Finnish cohort, 35 percent",
"    <span class=\"nowrap\">",
"     (7/20)",
"    </span>",
"    of patients prospectively evaluated had defective humoral immunity, most frequently IgA deficiency. Some individuals have hypogammaglobulinemia requiring immunoglobulin replacement. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/48/24326?source=see_link\">",
"     \"Primary humoral immune deficiencies: An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Discrimination between severe and more moderate forms of immunodeficiency in CHH is difficult and often not discernible with routine laboratory methods. However, individuals with CHH who have severe lymphopenia and immunoglobulin defects should be considered as high-risk for infection susceptibility. An additional confounding feature of CHH is that many patients with lymphopenia do not suffer recurrent infections [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Malignancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mortality in CHH is increased primarily owing to greater infection susceptibility in children and a higher incidence of hematologic malignancy among adults [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/22,34,35\">",
"     22,34,35",
"    </a>",
"    ]. Extended follow-up of a Finnish cohort of 123 patients revealed 14 cases of cancer, with an expected incidence of two based upon population-based data [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/35\">",
"     35",
"    </a>",
"    ]. Half of the malignancies were of B cell origin. Non-Hodgkin lymphoma was most common (n = 9), followed by squamous cell carcinoma (n = 3), leukemia (n = 1), and Hodgkin's disease (n = 1). Nine of the 14 cases occurred in patients between the ages of 15 and 44 years. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27610?source=see_link\">",
"     \"Clinical presentation and diagnosis of non-Hodgkin lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Individuals with CHH also display a unique predisposition to the development of basal cell carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/25,35\">",
"     25,35",
"    </a>",
"    ]. In the same Finnish cohort described above, an additional 10 patients had basal cell carcinoma of the skin, with an expected number of 0.3 cases for the population [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/35\">",
"     35",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/39/14970?source=see_link\">",
"     \"Epidemiology and clinical features of basal cell carcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Autoimmunity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Autoimmune disease is reported among individuals with CHH, including immune mediated thrombocytopenia (ITP), autoimmune hemolytic anemia (AIHA), and juvenile idiopathic arthritis (JIA) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/3,23\">",
"     3,23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/17/23833?source=see_link\">",
"     \"Clinical manifestations and diagnosis of immune thrombocytopenia (ITP) in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/59/18362?source=see_link\">",
"     \"Autoimmune hemolytic anemia in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/56/35717?source=see_link\">",
"     \"Classification of juvenile arthritis (JRA/JIA)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Pulmonary findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary complications reported in patients with CHH include mild to severe bronchiectasis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/36\">",
"     36",
"    </a>",
"    ] and chronic obstructive symptoms with diffuse dilated lymphoplasmacytic bronchiolitis that improves with antibiotic therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/24\">",
"     24",
"    </a>",
"    ]. Patients with bronchiectasis more often have a humoral immunodeficiency and worse growth failure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/10/12458?source=see_link\">",
"     \"Clinical manifestations and diagnosis of bronchiectasis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10076444\">",
"    <span class=\"h2\">",
"     Granuloma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epithelioid cell granulomatous inflammation was seen in 19 percent",
"    <span class=\"nowrap\">",
"     (4/21)",
"    </span>",
"    of patients in one series [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/37\">",
"     37",
"    </a>",
"    ]. All four patients had infiltrative skin lesions and one also had visceral organ involvement. One patient had spontaneous resolution of granulomas at 17 years of age. The other three patients had partial regression of lesions with anti-tumor necrosis factor (TNF) therapy in addition to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    . However, one of these patients died from viral progressive multifocal leukoencephalopathy. The granulomatous inflammation resolved completely in another of these patients after undergoing successful hematopoietic cell transplantation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Other features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dramatic clinical heterogeneity is observed within CHH sibships. This phenotype diversity within families makes presymptomatic diagnosis of immunodeficiency challenging, even when a previous sibling had immune problems. Similar findings are noted in other populations with different RMRP mutations [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     LABORATORY FINDINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Almost all persons with CHH will have some abnormal immune studies. However, there is not a clear pattern of immunodeficiency among people with CHH [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/3,12,20,39-41\">",
"     3,12,20,39-41",
"    </a>",
"    ]. Absolute lymphocyte counts and T cell counts for age are generally low, delayed type hypersensitivity responses are often impaired, and neutropenia is also reported [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/3\">",
"     3",
"    </a>",
"    ]. Lymphocyte proliferation to mitogens is generally suboptimal compared to controls [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/3\">",
"     3",
"    </a>",
"    ]. However, abnormal in vitro proliferation and lymphopenia do not necessarily indicate that a given individual will have a severe immunodeficiency. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/58/43945?source=see_link\">",
"     \"Laboratory evaluation of the immune system\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Antibody defects are also common in CHH persons [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/3,42\">",
"     3,42",
"    </a>",
"    ]. Hypogammaglobulinemia may be transient or persist throughout life. Selective IgA deficiency is described in some individuals and may be a marker for severe immunodeficiency in CHH [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/3\">",
"     3",
"    </a>",
"    ]. An individual with more than one immunoglobulin isotype deficiency should be considered high risk for infectious complications. Humoral immune defects may occur alone or in combination with cellular defects. In the latter case, the provisional diagnosis is severe combined immunodeficiency (SCID) until proven otherwise. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/48/24326?source=see_link\">",
"     \"Primary humoral immune deficiencies: An overview\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/30/42471?source=see_link\">",
"     \"Severe combined immunodeficiency (SCID): An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Anemia is also common among individuals with CHH. One retrospective study of 88 patients found a history of macrocytic or normocytic anemia in 73 percent during the childhood years [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/43\">",
"     43",
"    </a>",
"    ]. Severe anemia is rare; however, autoimmune hemolytic anemia (AIHA) and Diamond-Blackfan syndrome are reported in the setting of CHH [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/3,23,39\">",
"     3,23,39",
"    </a>",
"    ]. Thrombocytopenia is also reported. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/20/26954?source=see_link\">",
"     \"Anemia in children due to decreased red blood cell production\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical findings of short-limbed dwarfism and fine hair without manifestations of another skeletal dysplasia suggest the diagnosis of CHH. The diagnosis is probable in a patient with short stature among individuals with Finnish or Old Order Amish heritage. Analysis for RMRP sequence variants can confirm the diagnosis in a patient with skeletal dysplasia and associated clinical findings [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/1,4\">",
"     1,4",
"    </a>",
"    ]. All persons with short limbed dwarfism and clinical or laboratory evidence of immune deficiency should be evaluated for CHH.",
"   </p>",
"   <p>",
"    Radiographic findings are helpful in the workup of an individual with suspected skeletal dysplasia. The metaphyseal ends are abnormal in CHH and appear as scalloped, irregular surfaces that may contain cystic areas on routine radiographs [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/16\">",
"     16",
"    </a>",
"    ]. Metaphyseal changes vary depending upon the bone studied, but are universally abnormal in an individual with CHH.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of CHH includes other autosomal recessive skeletal dysplasias caused by mutations in the RMRP gene:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Anauxetic dysplasia &mdash; Features of anauxetic dysplasia (AD; MIM 607095) include severe spondyloepimetaphyseal dysplasia, mild mental retardation, and hypodontia. Immunodeficiency has not been reported in these patients.",
"     </li>",
"     <li>",
"      Metaphyseal dysplasia without hypotrichosis &mdash; Metaphyseal dysplasia is mild in patients with metaphyseal dysplasia without hypotrichosis (MDWH; MIM 250460). Immunodeficiency has not been reported in these patients.",
"     </li>",
"     <li>",
"      Kyphomelic dysplasia &mdash; Features of kyphomelic dysplasia (KD; MIM 211350) include metaphyseal dysplasia, combined immunodeficiency, facial dysmorphisms, and rib abnormalities.",
"     </li>",
"     <li>",
"      Shwachman-Diamond Syndrome &mdash; This syndrome with metaphyseal dysplasia has associated hematologic abnormalities, such as neutropenia, and exocrine pancreatic dysfunction (MIM 260400).",
"     </li>",
"     <li>",
"      Ectodermal Dysplasia with Immune Deficiency &mdash; The features associated with this syndrome include abnormal teeth, hair, and eccrine sweat glands, and immune deficiency with dysgammaglobulinemia and recurrent infections (MIM 300921).",
"     </li>",
"     <li>",
"      Growth Hormone Insensitivity with Immunodeficiency &mdash; This syndrome of postnatal growth failure and recurrent infections is associated with mutations in STAT5b (MIM 604260).",
"     </li>",
"     <li>",
"      Schimke Immuno-osseous Dysplasia &mdash; Skeletal anomalies, such as spondyloepiphyseal dysplasia and associated cellular immune dysfunction are reported (MIM 242900). This syndrome is also associated with immune complex nephritis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    CHH differs clinically from another autosomal recessive skeletal dysplasia first reported in Old Order Amish, the Ellis-van Creveld syndrome (EVC; MIM 225500). Persons with EVC have postaxial polydactyly and a high incidence of congenital heart disease, but do not have associated immune defects [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/44\">",
"     44",
"    </a>",
"    ]. Additional distinguishing features of EVC syndrome include dysplastic nails and natal teeth [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/44,45\">",
"     44,45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Optimal management of CHH, similar to that for any complex genetic disease, requires a medical home base where the patient can be seen promptly for acute illnesses, managed longitudinally for chronic problems, and monitored for the manifold problems associated with this syndrome. Surveillance for immunodeficiency, malignancy, and autoimmune disease is important for all people with CHH, and should be part of every clinical visit.",
"   </p>",
"   <p>",
"    Infants should be evaluated for severe combined immunodeficiency (SCID) and have close surveillance for infections. We do not recommend giving the live",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/50/42789?source=see_link\">",
"     rotavirus vaccine",
"    </a>",
"    during the first year of life. MMR and varicella vaccines may be given early in the second year of life in individuals without combined immunodeficiency or SCID (",
"    <a class=\"graphic graphic_algorithm graphicRef50065 \" href=\"UTD.htm?17/59/18367\">",
"     algorithm 1",
"    </a>",
"    ). We recommend all other routine vaccines for infants, children, and adults without exception. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/30/42471?source=see_link\">",
"     \"Severe combined immunodeficiency (SCID): An overview\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/27/8633?source=see_link\">",
"     \"Medical management of immune deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hematopoietic cell transplantation (HCT) is curative for SCID in the setting of CHH and associated autoimmunity also resolves after transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/3,46,47\">",
"     3,46,47",
"    </a>",
"    ]. However, HCT does not improve the musculoskeletal or growth features of the syndrome. Risk stratification for serious immunodeficiency is difficult unless the patient has alymphocytosis and classic SCID presentation. Thus, determining who will benefit from HCT is not always clear. Transplantation before the development of serious infections, significant organ damage, or malignancy improves survival for those patients who clearly have combined immunodeficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/47\">",
"     47",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/2/1066?source=see_link\">",
"     \"Hematopoietic cell transplantation for primary immunodeficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Careful attention to bowel function during the first year of life is prudent. Hirschsprung disease (HD) is common in CHH. Some patients with CHH present outside of the newborn period with only mild constipation, with the diagnosis of HD established near six months of age [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/48\">",
"     48",
"    </a>",
"    ]. Any bloody stools in an infant with CHH should prompt an evaluation for HD and associated enterocolitis, because enterocolitis may be the heralding sign of HD. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41848?source=see_link\">",
"     \"Congenital aganglionic megacolon (Hirschsprung disease)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Growth monitoring in CHH is essential. CHH specific growth charts are not readily available, but monitoring with standard growth charts is still useful to ensure steady progress. Delayed or diminished head growth is not typical in CHH and warrants further evaluation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/51/36665?source=see_link&amp;anchor=H16#H16\">",
"     \"Etiology and evaluation of microcephaly in infants and children\", section on 'Evaluation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42633?source=see_link&amp;anchor=H13#H13\">",
"     \"Normal growth patterns in infants and prepubertal children\", section on 'Evaluation of growth'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Because adults may present with severe bronchiectasis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/36\">",
"     36",
"    </a>",
"    ], we recommend routine surveillance for obstructive lung disease with periodic spirometry",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pulmonary function testing. Any chronic pulmonary infections or significant abnormalities of pulmonary function warrant further investigation with computed tomography (CT) of the chest.",
"   </p>",
"   <p>",
"    Surveillance for musculoskeletal disease, such as scoliosis, symptomatic genu and ankle varus, and arthritides later in life should be part of routine evaluations of CHH patients. Surgical correction may be needed for symptomatic scoliosis or large joint arthritis. Some individuals benefit from joint replacement surgery or arthroscopy, although a comprehensive analysis of these interventions and their benefit for CHH is lacking.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individuals with CHH have normal intelligence and achieve normal developmental milestones throughout childhood. Lifespan can be shortened in patients with CHH secondary to a significant immunodeficiency in childhood or lymphoma and leukemia in adulthood. Severe bronchiectasis may also dramatically shorten lifespan of persons with CHH [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/36\">",
"     36",
"    </a>",
"    ]. Analysis of 120 Finnish CHH patients between 1971 and 1995 revealed a standardized mortality ratio (SMR, the ratio of observed to expected deaths) of 380 for infectious complications in childhood (&lt; age 14 years) and an SMR of 52 for hematologic malignancies among persons older than 15 years [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/22\">",
"     22",
"    </a>",
"    ]. Extended follow-up of the Finnish cohort (n = 123) reported individuals living into the seventh decade, indicating that normal duration of life is possible for individuals with CHH [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7992/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cartilage-hair hypoplasia (CHH) is a rare autosomal recessive form of short-limb dwarfism (metaphyseal chondrodysplasia). (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Associated features may include fine sparse hair, cellular and humoral immunodeficiencies, Hirschsprung disease, hematologic and skin malignancies, autoimmune disease, and bronchiectasis. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      CHH is caused by defects in the ribonuclease mitochondrial RNA-processing (RMRP) gene. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Genetics and pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis is suspected in patients with typical clinical and radiologic features and is confirmed with mutation analysis of the RMRP gene. Both are necessary to make a diagnosis of CHH. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis includes other autosomal recessive skeletal dysplasias. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment of CHH includes monitoring for and treating infections, gastrointestinal abnormalities, malignancy, autoimmune disease, and pulmonary complications. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Lifespan can be shortened in patients with CHH secondary to a significant immunodeficiency in childhood or lymphoma and leukemia in adulthood. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/1\">",
"      Ridanp&auml;&auml; M, van Eenennaam H, Pelin K, et al. Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia. Cell 2001; 104:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/2\">",
"      MCKUSICK VA, ELDRIDGE R, HOSTETLER JA, et al. DWARFISM IN THE AMISH. II. CARTILAGE-HAIR HYPOPLASIA. Bull Johns Hopkins Hosp 1965; 116:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/3\">",
"      Rider NL, Morton DH, Puffenberger E, et al. Immunologic and clinical features of 25 Amish patients with RMRP 70 A--&gt;G cartilage hair hypoplasia. Clin Immunol 2009; 131:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/4\">",
"      Ridanp&auml;&auml; M, Jain P, McKusick VA, et al. The major mutation in the RMRP gene causing CHH among the Amish is the same as that found in most Finnish cases. Am J Med Genet C Semin Med Genet 2003; 121C:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/5\">",
"      M&auml;kitie O. Cartilage-hair hypoplasia in Finland: epidemiological and genetic aspects of 107 patients. J Med Genet 1992; 29:652.",
"     </a>",
"    </li>",
"    <li>",
"     Kraybill D. Concise Encyclopedia of Amish, Brethren, Hutterites and Mennonites, Johns Hopkins Universtiy Press, Baltimore 2010.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/7\">",
"      Roifman CM, Gu Y, Cohen A. Mutations in the RNA component of RNase mitochondrial RNA processing might cause Omenn syndrome. J Allergy Clin Immunol 2006; 117:897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/8\">",
"      Ridanp&auml;&auml; M, Sistonen P, Rockas S, et al. Worldwide mutation spectrum in cartilage-hair hypoplasia: ancient founder origin of the major70A--&gt;G mutation of the untranslated RMRP. Eur J Hum Genet 2002; 10:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/9\">",
"      Bonaf&eacute; L, Dermitzakis ET, Unger S, et al. Evolutionary comparison provides evidence for pathogenicity of RMRP mutations. PLoS Genet 2005; 1:e47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/10\">",
"      Hermanns P, Tran A, Munivez E, et al. RMRP mutations in cartilage-hair hypoplasia. Am J Med Genet A 2006; 140:2121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/11\">",
"      Hirose Y, Nakashima E, Ohashi H, et al. Identification of novel RMRP mutations and specific founder haplotypes in Japanese patients with cartilage-hair hypoplasia. J Hum Genet 2006; 51:706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/12\">",
"      Notarangelo LD, Roifman CM, Giliani S. Cartilage-hair hypoplasia: molecular basis and heterogeneity of the immunological phenotype. Curr Opin Allergy Clin Immunol 2008; 8:534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/13\">",
"      Thiel CT, Mortier G, Kaitila I, et al. Type and level of RMRP functional impairment predicts phenotype in the cartilage hair hypoplasia-anauxetic dysplasia spectrum. Am J Hum Genet 2007; 81:519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/14\">",
"      M&auml;kitie O. [Cartilage-hair hypoplasia--a Finnish growth disorder]. Duodecim 1993; 109:1638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/15\">",
"      M&auml;kitie O, Kaitila I. Cartilage-hair hypoplasia--clinical manifestations in 108 Finnish patients. Eur J Pediatr 1993; 152:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/16\">",
"      M&auml;kitie O, Marttinen E, Kaitila I. Skeletal growth in cartilage-hair hypoplasia. A radiological study of 82 patients. Pediatr Radiol 1992; 22:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/17\">",
"      M&auml;kitie O, Perheentupa J, Kaitila I. Growth in cartilage-hair hypoplasia. Pediatr Res 1992; 31:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/18\">",
"      M&auml;kitie O, Sulisalo T, de la Chapelle A, Kaitila I. Cartilage-hair hypoplasia. J Med Genet 1995; 32:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/19\">",
"      M&auml;kitie O, Heikkinen M, Kaitila I, Rintala R. Hirschsprung's disease in cartilage-hair hypoplasia has poor prognosis. J Pediatr Surg 2002; 37:1585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/20\">",
"      Lux SE, Johnston RB Jr, August CS, et al. Chronic neutropenia and abnormal cellular immunity in cartilage-hair hypoplasia. N Engl J Med 1970; 282:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/21\">",
"      Coupe RL, Lowry RB. Abnormality of the hair in cartilage-hair hypoplasia. Dermatologica 1970; 141:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/22\">",
"      M&auml;kitie O, Pukkala E, Kaitila I. Increased mortality in cartilage-hair hypoplasia. Arch Dis Child 2001; 84:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/23\">",
"      Ashby GH, Evans DI. Cartilage hair hypoplasia with thrombocytopenic purpura, autoimmune haemolytic anaemia and cell-mediated immunodeficiency. J R Soc Med 1986; 79:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/24\">",
"      Bailly-Botuha C, Jaubert F, Taam RA, et al. Diffuse lymphoplasmacytic bronchiolitis in cartilage-hair hypoplasia. J Pediatr 2008; 152:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/25\">",
"      Eisner JM, Russell M. Cartilage hair hypoplasia and multiple basal cell carcinomas. J Am Acad Dermatol 2006; 54:S8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/26\">",
"      Ferber B, Bruckheimer E, Schlesinger Y, et al. Kingella kingae endocarditis in a child with hair-cartilage hypoplasia. Pediatr Cardiol 1997; 18:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/27\">",
"      M&auml;kitie O, Kaitila I, Savilahti E. Susceptibility to infections and in vitro immune functions in cartilage-hair hypoplasia. Eur J Pediatr 1998; 157:816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/28\">",
"      Polmar SH, Pierce GF. Cartilage hair hypoplasia: immunological aspects and their clinical implications. Clin Immunol Immunopathol 1986; 40:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/29\">",
"      Saulsbury FT, Winkelstein JA, Davis LE, et al. Combined immunodeficiency and vaccine-related poliomyelitis in a child with cartilage-hair hypoplasia. J Pediatr 1975; 86:868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/30\">",
"      Buckley RH, Schiff SE, Schiff RI, et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 1999; 340:508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/31\">",
"      Castigli E, Irani AM, Geha RS, Chatila T. Defective expression of early activation genes in cartilage-hair hypoplasia (CHH) with severe combined immunodeficiency (SCID). Clin Exp Immunol 1995; 102:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/32\">",
"      Guggenheim R, Somech R, Grunebaum E, et al. Bone marrow transplantation for cartilage-hair-hypoplasia. Bone Marrow Transplant 2006; 38:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/33\">",
"      Steele RW, Britton HA, Anderson CT, Kniker WT. Severe combined immunodeficiency with cartilage-hair hypoplasa: in vitro response to thymosin and attempted reconstitution. Pediatr Res 1976; 10:1003.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/34\">",
"      M&auml;kitie O, Pukkala E, Teppo L, Kaitila I. Increased incidence of cancer in patients with cartilage-hair hypoplasia. J Pediatr 1999; 134:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/35\">",
"      Taskinen M, Ranki A, Pukkala E, et al. Extended follow-up of the Finnish cartilage-hair hypoplasia cohort confirms high incidence of non-Hodgkin lymphoma and basal cell carcinoma. Am J Med Genet A 2008; 146A:2370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/36\">",
"      Toiviainen-Salo S, Kajosaari M, Piilonen A, M&auml;kitie O. Patients with cartilage-hair hypoplasia have an increased risk for bronchiectasis. J Pediatr 2008; 152:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/37\">",
"      Moshous D, Meyts I, Fraitag S, et al. Granulomatous inflammation in cartilage-hair hypoplasia: risks and benefits of anti-TNF-&alpha; mAbs. J Allergy Clin Immunol 2011; 128:847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/38\">",
"      Kavadas FD, Giliani S, Gu Y, et al. Variability of clinical and laboratory features among patients with ribonuclease mitochondrial RNA processing endoribonuclease gene mutations. J Allergy Clin Immunol 2008; 122:1178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/39\">",
"      Harris RE, Baehner RL, Gleiser S, et al. Cartilage-hair hypoplasia, defective T-cell function, and Diamond-Blackfan anemia in an Amish child. Am J Med Genet 1981; 8:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/40\">",
"      M&auml;kitie O, Juvonen E, Dunkel L, et al. Anemia in children with cartilage-hair hypoplasia is related to body growth and to the insulin-like growth factor system. J Clin Endocrinol Metab 2000; 85:563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/41\">",
"      Ranki A, Perheentupa J, Andersson LC, H&auml;yry P. In vitro T- and B-cell reactivity in cartilage hair hypoplasia. Clin Exp Immunol 1978; 32:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/42\">",
"      M&auml;kitie O, Kaitila I, Savilahti E. Deficiency of humoral immunity in cartilage-hair hypoplasia. J Pediatr 2000; 137:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/43\">",
"      M&auml;kitie O, Rajantie J, Kaitila I. Anaemia and macrocytosis--unrecognized features in cartilage-hair hypoplasia. Acta Paediatr 1992; 81:1026.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/44\">",
"      MCKUSICK VA, EGELAND JA, ELDRIDGE R, KRUSEN DE. DWARFISM IN THE AMISH I. THE ELLIS-VAN CREVELD SYNDROME. Bull Johns Hopkins Hosp 1964; 115:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/45\">",
"      Ruiz-Perez VL, Tompson SW, Blair HJ, et al. Mutations in two nonhomologous genes in a head-to-head configuration cause Ellis-van Creveld syndrome. Am J Hum Genet 2003; 72:728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/46\">",
"      Berthet F, Siegrist CA, Ozsahin H, et al. Bone marrow transplantation in cartilage-hair hypoplasia: correction of the immunodeficiency but not of the chondrodysplasia. Eur J Pediatr 1996; 155:286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/47\">",
"      Bordon V, Gennery AR, Slatter MA, et al. Clinical and immunologic outcome of patients with cartilage hair hypoplasia after hematopoietic stem cell transplantation. Blood 2010; 116:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7992/abstract/48\">",
"      Gu&eth;mundsd&oacute;ttir ES, Bjarnason G, Magn&uacute;sson J. [Hirschprung' disease in Iceland 1969-1998.]. Laeknabladid 2001; 87:987.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3916 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-203.80.222.8-CDD449C725-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_51_7992=[""].join("\n");
var outline_f7_51_7992=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      GENETICS AND PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Somatic growth and musculoskeletal findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Gastrointestinal abnormalities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Hair abnormalities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Immunodeficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Malignancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Autoimmunity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Pulmonary findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10076444\">",
"      Granuloma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Other features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      LABORATORY FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/3916\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/3916|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?17/59/18367\" title=\"algorithm 1\">",
"      CHH management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/3916|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?2/54/2914\" title=\"picture 1\">",
"      Toddler with CHH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?8/2/8224\" title=\"picture 2\">",
"      Adult with CHH",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/20/26954?source=related_link\">",
"      Anemia in children due to decreased red blood cell production",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/59/18362?source=related_link\">",
"      Autoimmune hemolytic anemia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/56/35717?source=related_link\">",
"      Classification of juvenile arthritis (JRA/JIA)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/10/12458?source=related_link\">",
"      Clinical manifestations and diagnosis of bronchiectasis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/17/23833?source=related_link\">",
"      Clinical manifestations and diagnosis of immune thrombocytopenia (ITP) in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27610?source=related_link\">",
"      Clinical presentation and diagnosis of non-Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/58/40873?source=related_link\">",
"      Combined immunodeficiencies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41848?source=related_link\">",
"      Congenital aganglionic megacolon (Hirschsprung disease)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/39/14970?source=related_link\">",
"      Epidemiology and clinical features of basal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/51/36665?source=related_link\">",
"      Etiology and evaluation of microcephaly in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/2/1066?source=related_link\">",
"      Hematopoietic cell transplantation for primary immunodeficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/58/43945?source=related_link\">",
"      Laboratory evaluation of the immune system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/27/8633?source=related_link\">",
"      Medical management of immune deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42633?source=related_link\">",
"      Normal growth patterns in infants and prepubertal children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/48/24326?source=related_link\">",
"      Primary humoral immune deficiencies: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/30/42471?source=related_link\">",
"      Severe combined immunodeficiency (SCID): An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/0/10?source=related_link\">",
"      Severe combined immunodeficiency (SCID): Specific defects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/22/40295?source=related_link\">",
"      Syndromic immunodeficiencies",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_51_7993="Nutritional issues in food allergy";
var content_f7_51_7993=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Nutritional issues in food allergy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/51/7993/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/51/7993/contributors\">",
"     Marion Groetch, MS, RD, CDN",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/51/7993/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/51/7993/contributors\">",
"     Scott H Sicherer, MD, FAAAAI",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/51/7993/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/51/7993/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?7/51/7993/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 9, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goals of nutritional intervention in patients with food allergy are twofold: prevent acute and chronic food allergic reactions through allergen elimination and ensure adequate nutrition within the context of the allergen-restricted diet.",
"   </p>",
"   <p>",
"    Nutritional management of food allergy requires careful planning to ensure that the nutrients inherent in the eliminated food(s) are adequately replaced. Nutrient dense alternative food sources should be recommended when elimination diets are initiated. Follow-up to ensure that the alternative nutrient sources have been accepted and incorporated into the diet is also recommended.",
"   </p>",
"   <p>",
"    This topic will focus on the prevention of nutritional problems that can arise with food elimination diets. Food allergen avoidance is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/48/18185?source=see_link\">",
"     \"Management of food allergy: Avoidance\"",
"    </a>",
"    and",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?34/35/35379?source=see_link\">",
"     \"Patient information: Food allergy treatment and avoidance (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The indications for nutritional assessment, clinical features of nutrition disorders, measurements of growth, and laboratory evaluation of nutritional status are also discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/40/36487?source=see_link\">",
"     \"Indications for nutritional assessment in childhood\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/14/31976?source=see_link\">",
"     \"Measurement of growth in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/55/22391?source=see_link\">",
"     \"Laboratory and radiologic evaluation of nutritional status in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/40/23175?source=see_link\">",
"     \"Dietary and nutritional assessment in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GENERAL NUTRITION AND FOOD ALLERGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dietary limitations secondary to food allergy can lead to failure to thrive",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    deficiencies in specific macro and micronutrients. Several studies demonstrate that children with food allergies have lower intakes of total energy and",
"    <span class=\"nowrap\">",
"     macro/micronutrients",
"    </span>",
"    than children without food allergy [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pediatric clinicians should closely monitor the growth of children with food allergy and refer such patients to a registered dietitian for evaluation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42633?source=see_link&amp;anchor=H13#H13\">",
"     \"Normal growth patterns in infants and prepubertal children\", section on 'Evaluation of growth'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Energy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient with food allergies is at risk of insufficient energy intake due to inadequate substitution in the allergen elimination diet. Additionally, feeding problems such as food aversion and limited acceptance of a variety of foods may occur in children with food allergies and may significantly contribute to poor energy and overall nutrient intake. Certain food allergic disorders, such as allergic eosinophilic esophagitis and gastroenteritis, are commonly accompanied by poor appetite and early satiety, potentially contributing to decreased energy intake [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/45/32474?source=see_link\">",
"     \"Pathogenesis, clinical manifestations, and diagnosis of eosinophilic esophagitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Estimated energy needs for those with food allergies are generally similar to energy needs of those without food allergies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/0/18441?source=see_link&amp;anchor=H3#H3\">",
"     \"Dietary recommendations for toddlers, preschool, and school-age children\", section on 'Energy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/43/10938?source=see_link&amp;anchor=H2#H2\">",
"     \"Introducing solid foods and vitamin and mineral supplementation during infancy\", section on 'Infant nutritional requirements'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One exception is patients with moderate to severe atopic dermatitis, who may have increased energy and protein needs due to losses through the compromised skin barrier [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Energy is provided in the diet through three primary classes of macronutrients:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Proteins",
"     </li>",
"     <li>",
"      Carbohydrates",
"     </li>",
"     <li>",
"      Fats",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Acceptable Macronutrient Distribution Ranges (AMDR) indicate the range of intake for a particular energy source, expressed as a percentage of total caloric intake that is associated with reduced risk of chronic disease while providing adequate intakes of essential nutrients (",
"    <a class=\"graphic graphic_table graphicRef69697 \" href=\"UTD.htm?15/26/15787\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Macronutrient intake should be considered in the nutritional assessment and recommendations for dietary modifications to ensure appropriate intake and distribution of carbohydrates, fats, and proteins. Finding a nutritional balance as well as meeting recommended dietary intakes can often be challenging when food groups are eliminated due to food allergies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Protein",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many excellent sources of protein are also common allergens, including milk, egg, soy, fish, shellfish, peanut, and tree nuts. Diets must be carefully planned to meet protein needs when high quality protein sources are eliminated from the diet.",
"   </p>",
"   <p>",
"    Although rare in affluent countries when unrelated to chronic illness, cases of kwashiorkor have been reported in patients with food allergies [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/7\">",
"     7",
"    </a>",
"    ]. In a review of 12 cases of kwashiorkor referred to tertiary care centers in the United States (age range 1 to 22 months), one-half were the result of a deliberate deviation from a standard diet due to suspected food allergies without adequate protein in the diet [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/7\">",
"     7",
"    </a>",
"    ]. Inadequate dietary protein intake may also contribute to decreased stature reportedly seen in children with food allergies [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/1,8,9\">",
"     1,8,9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/31/32248?source=see_link&amp;anchor=H2#H2\">",
"     \"Malnutrition in developing countries: Clinical assessment\", section on 'Protein-energy malnutrition'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Quality and quantity of dietary protein must be considered, as well as total energy intake, when assessing adequacy of protein in the diet [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/6\">",
"     6",
"    </a>",
"    ]. The AMDR for protein is 5 to 20 percent for children 1 to 3 years of age, 10 to 30 percent for children 4 to 18 years of age, and 10 to 35 percent for adults. Dietary protein recommendations are based upon the assumption that energy intake is adequate. If energy intake is insufficient, free amino acids will be oxidized for energy, allowing for less available amino acids for anabolic and synthetic pathways [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An estimated 65 to 70 percent of protein intake should come from sources of high biologic value, typically animal products, which contain a full complement of essential amino acids. Animal products are not necessary to provide optimal protein, but most alternative sources from plants (eg, legumes, grains, nuts, seeds, and vegetables) do not contain a full complement of essential amino acids. Thus, greater dietary planning is required for diets without meats. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/61/28631?source=see_link\">",
"     \"Dietary history and recommended dietary intake in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/4/8266?source=see_link\">",
"     \"Vegetarian diets for children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Fat",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dietary fat is an important source of energy, supports the transport of fat-soluble vitamins, and provides the two essential fatty acids, alpha-linolenic acid (ALA) and linoleic acid (LA). Assessing fat intake in the patient with food allergy is a simple, but often overlooked, step in the nutrition evaluation.",
"   </p>",
"   <p>",
"    The AMDR for fat is 25 to 35 percent of total energy intake for older children and adults (30 to 40 percent for children 1 to 3 years of age). It should not be below 20 percent. The risk of insufficient energy, vitamin E, and essential fatty acids increases when fat intake falls below 20 percent of the total dietary energy intake [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/6,10\">",
"     6,10",
"    </a>",
"    ]. Essential fatty acid (EFA) deficiency is rare. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/4/38983?source=see_link\">",
"     \"Micronutrient deficiencies associated with malnutrition in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    To meet fat recommendations (AMDR), most dietary fats should come from monounsaturated and polyunsaturated sources (",
"    <a class=\"graphic graphic_table graphicRef80214 \" href=\"UTD.htm?17/42/18091\">",
"     table 2",
"    </a>",
"    ). Intake of saturated and transfatty acids should be kept as low as possible (&lt;10 percent of total energy intake in children &gt;2 years and adults and preferably none, respectively). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/34/2601?source=see_link\">",
"     \"Dietary fat\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/0/18441?source=see_link&amp;anchor=H5#H5\">",
"     \"Dietary recommendations for toddlers, preschool, and school-age children\", section on 'Fat'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The recommended intake for LA is easily met as LA is abundant in most diets and is found in a wide variety of vegetable oils (",
"    <a class=\"graphic graphic_table graphicRef80214 \" href=\"UTD.htm?17/42/18091\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef51635 \" href=\"UTD.htm?7/1/7198\">",
"     figure 1",
"    </a>",
"    ). ALA is less abundantly found and the sources tend to be from more commonly allergenic foods.",
"   </p>",
"   <p>",
"    Dietary fat is present in a wide variety of foods such as dairy products, eggs, meat, fish, poultry, vegetable oils and margarines, and many convenience foods. Treatment of food allergy often results in the elimination of the allergen as well as many manufactured food products that contain the allergen. The resulting diet tends to come from primarily whole foods rather than processed foods, which may result in inadequate fat intake if additional fat is not added to the diet.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Replacement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vegetable oils are usually added to the allergen-restricted diet when fat and EFA needs are not met (",
"    <a class=\"graphic graphic_table graphicRef80214 \" href=\"UTD.htm?17/42/18091\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef51635 \" href=\"UTD.htm?7/1/7198\">",
"     figure 1",
"    </a>",
"    ). The amount and type of oil used is individualized based upon current dietary intake and degree and type of dietary restrictions. Adding fats that are predominantly monounsaturated and polyunsaturated and those that contain at least 10 percent of daily EFA requirements are preferred. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/0/18441?source=see_link&amp;anchor=H15#H15\">",
"     \"Dietary recommendations for toddlers, preschool, and school-age children\", section on 'Fat and cholesterol'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Carbohydrate",
"    </span>",
"    &nbsp;&mdash;&nbsp;Carbohydrates make up the remaining energy sources and supply numerous vitamins, minerals, and trace elements. Individuals with grain allergies may have an especially difficult time ingesting sufficient carbohydrates without appropriate grain substitutions in addition to adequate fruit and vegetable intake.",
"   </p>",
"   <p>",
"    The AMDR for carbohydrate is between 45 to 65 percent of total caloric intake [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/11\">",
"     11",
"    </a>",
"    ]. The RDA is 130",
"    <span class=\"nowrap\">",
"     grams/day",
"    </span>",
"    for children one year of age and older and adults, based upon the role of carbohydrates as the primary source of energy for the brain [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Micronutrients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Micronutrients include vitamins, minerals and trace elements. Variety in the diet contributes to adequacy of all nutrients provided. When a food group is eliminated, many nutrients provided by that food group must now be provided by other dietary sources.",
"   </p>",
"   <p>",
"    Dietary Reference Intakes (DRI) for micronutrients are available through the United States Department of Agriculture Food and Nutrition Center (",
"    <a class=\"external\" href=\"file://fnic.nal.usda.gov/nal_display/index.php?info_center=4&amp;tax_level=3&amp;tax_subject=256&amp;topic_id=1342&amp;level3_id=5140\">",
"     file://fnic.nal.usda.gov/nal_display/index.php?info_center=4&amp;tax_level=3&amp;tax_subject=256&amp;topic_id=1342&amp;level3_id=5140",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/61/28631?source=see_link&amp;anchor=H11#H11\">",
"     \"Dietary history and recommended dietary intake in children\", section on 'Dietary Reference Intakes (DRIs)'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is important to ensure adequate intake of all essential nutrients in children with food allergies. However, there is a greater risk of insufficiency of certain nutrients, depending upon the food allergen(s) avoided. These nutrients must be adequately replaced by other foods in the diet (",
"    <a class=\"graphic graphic_table graphicRef55081 \" href=\"UTD.htm?29/52/30539\">",
"     table 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef54072 \" href=\"UTD.htm?22/35/23099\">",
"     table 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef74067 \" href=\"UTD.htm?6/18/6443\">",
"     table 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef72372 \" href=\"UTD.htm?30/50/31531\">",
"     table 6",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Supplementation is considered when dietary modifications are inadequate to meet vitamin, mineral, and trace element needs. However, dietary supplements may be contaminated with the very food allergen(s) the patient is trying to avoid (even those products labeled allergen-free). Thus, the risk of potential cross contact during manufacturing or presence of residual allergen after processing should be assessed when considering a supplement [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     MONITORING GROWTH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Growth in children is a sensitive indicator of adequate energy and protein intake. Weight is the most sensitive measure of adequate energy intake and is affected earlier and to a greater extent than stature by dietary inadequacies. Stature can be delayed due to dietary protein inadequacy or chronic energy deficits. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/18/10537?source=see_link\">",
"     \"Causes of short stature\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/60/18376?source=see_link\">",
"     \"Diagnostic approach to short stature\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/31/32248?source=see_link\">",
"     \"Malnutrition in developing countries: Clinical assessment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/21/38233?source=see_link&amp;anchor=H6#H6\">",
"     \"Poor weight gain in children older than two years of age\", section on 'Limited or inappropriate intake'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/12/14538?source=see_link&amp;anchor=H3#H3\">",
"     \"Etiology and evaluation of failure to thrive (undernutrition) in children younger than two years\", section on 'Patterns of growth'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Plotting a child's weight history on the appropriate growth chart (World Health Organization growth charts (",
"    <a class=\"external\" href=\"file://www.who.int/childgrowth/standards/en/\">",
"     www.who.int/childgrowth/standards/en/",
"    </a>",
"    ) for children younger than two years of age and Centers for Disease Control and National Center for Health Statistics growth charts (",
"    <a class=\"external\" href=\"file://www.cdc.gov/growthcharts\">",
"     www.cdc.gov/growthcharts",
"    </a>",
"    ) for older children) provides a way to follow the typical growth patterns for that child as well as compare those patterns with that of the healthy reference population [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/13\">",
"     13",
"    </a>",
"    ]. The reference lines on the WHO growth charts are either percentile lines or z-scores; z-scores are units of standard deviation from the median. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/14/31976?source=see_link&amp;anchor=H2#H2\">",
"     \"Measurement of growth in children\", section on 'Growth standards'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42633?source=see_link&amp;anchor=H13#H13\">",
"     \"Normal growth patterns in infants and prepubertal children\", section on 'Evaluation of growth'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/30/19943?source=see_link&amp;anchor=H7#H7\">",
"     \"The pediatric physical examination: General principles and standard measurements\", section on 'Standard measurements'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Children with food allergies are at greater risk of inadequate growth and suboptimal nutrition than those without food allergies [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/1,2,8,9\">",
"     1,2,8,9",
"    </a>",
"    ]. Thus, children with food allergies, especially multiple food allergies or allergies to foods that are staples in the diet, should be referred for nutritional counseling, since dietary counseling may significantly improve nutritional intake and prevent nutritional deficiencies and growth failure. Recommending nutrient dense alternatives to the eliminated food at diagnosis and ensuring that the alternative food is accepted and incorporated into the diet are essential preventative measures. The primary care provider may recommend a dietitian or in the United States one may be found through the American Dietetic Association (",
"    <a class=\"external\" href=\"file://www.eatright.org/\">",
"     www.eatright.org",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/40/36487?source=see_link\">",
"     \"Indications for nutritional assessment in childhood\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/14/31976?source=see_link\">",
"     \"Measurement of growth in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/61/28631?source=see_link\">",
"     \"Dietary history and recommended dietary intake in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     FOOD ELIMINATION DIETS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Food elimination diets are an essential component of the management of patients with food allergy [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/14\">",
"     14",
"    </a>",
"    ]. However, they should only be undertaken with close clinical supervision, preferably with the guidance of an allergy specialist",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    gastroenterologist. Foods should not be eliminated based upon results from unvalidated testing methods. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/48/18185?source=see_link\">",
"     \"Management of food allergy: Avoidance\"",
"    </a>",
"    and",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?34/35/35379?source=see_link\">",
"     \"Patient information: Food allergy treatment and avoidance (Beyond the Basics)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/17/26904?source=see_link\">",
"     \"History and physical examination in the patient with possible food allergy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/12/5321?source=see_link&amp;anchor=H17#H17\">",
"     \"Diagnostic evaluation of food allergy\", section on 'Unvalidated methods'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Food elimination diets may impact nutrient intake. Thus, care must be taken to ensure that the restricted diet continues to provide adequate nutrition. This is especially important in children, in whom nutritional deficits may impact growth and development. Rickets, vitamin and mineral deficiencies, and suboptimal growth and failure to thrive are all associated with food elimination diets [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/1,2,8,15-19\">",
"     1,2,8,15-19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Complete elimination of a food allergen without also including safe and appropriate nutrient-dense substitutions will probably lead to nutritional inadequacies [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/5\">",
"     5",
"    </a>",
"    ]. In addition to suggesting substitutions, it is also important to follow-up with the patient to ensure that the alternative nutrient sources have been accepted and incorporated into the diet.",
"   </p>",
"   <p>",
"    Eight",
"    <span class=\"nowrap\">",
"     foods/food",
"    </span>",
"    groups are responsible for 90 percent of all food allergic reactions in the United States. The most common significant food allergens in adults are peanut, tree nuts, fish, and shellfish. Common food allergens of early childhood are cow's milk, hen's egg, wheat, soybean, and peanut [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. Cow's milk allergy (CMA), wheat allergy, and multiple food allergies present the greatest nutritional challenges. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/48/18185?source=see_link\">",
"     \"Management of food allergy: Avoidance\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Cow's milk allergy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adults with cow's milk allergy (CMA) are at risk of vitamin D and calcium deficiency, because it is difficult to meet calcium needs through non-dairy sources without careful substitution. The nutritional impact of cow's milk elimination in children is even greater, since milk is the primary source of fat, protein, calcium, and vitamin D for most children (",
"    <a class=\"graphic graphic_table graphicRef74819 \" href=\"UTD.htm?17/16/17676\">",
"     table 7",
"    </a>",
"    ). Milk also provides vitamin B12, vitamin A, pantothenic acid (vitamin B5), riboflavin, and phosphorus. Finding a nutritionally dense substitute for cow's milk in the pediatric diet is essential. Alternative dietary sources for these nutrients are available (",
"    <a class=\"graphic graphic_table graphicRef55081 \" href=\"UTD.htm?29/52/30539\">",
"     table 3",
"    </a>",
"    ). Vitamin D supplementation is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29640?source=see_link\">",
"     \"Milk allergy: Clinical features and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/9/40087?source=see_link\">",
"     \"Milk allergy: Management\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/38/28266?source=see_link&amp;anchor=H23365817#H23365817\">",
"     \"Vitamin D insufficiency and deficiency in children and adolescents\", section on 'Recommendations for vitamin D intake'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Breastfed infants",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nursing mothers of infants with CMA should avoid milk protein in their diet, since immunologically recognizable proteins from the maternal diet are found in breast milk [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/22\">",
"     22",
"    </a>",
"    ]. The nutritional adequacy of the maternal diet may need to be assessed, since dairy elimination may compromise maternal nutrient intake [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/23\">",
"     23",
"    </a>",
"    ]. Maternal dietary calcium replacement or calcium supplementation (1000",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    is recommended to maintain maternal stores [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/24\">",
"     24",
"    </a>",
"    ]. Vitamin D and vitamin A concentration in breast milk is reduced if the maternal diet is deficient, but calcium content of breast milk may not be affected by maternal intake [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. The lactating mother may benefit from continuing on a milk free prenatal vitamin supplement. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/53/43864?source=see_link\">",
"     \"Maternal nutrition during lactation\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H13\">",
"     'Formula fed infants'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Formula fed infants",
"    </span>",
"    &nbsp;&mdash;&nbsp;Formula fed infants with CMA need to avoid intact cow's milk-protein formulas. A summary report from an international consensus panel of allergy specialists (the Diagnosis and Rationale for Action against Cow&rsquo;s Milk Allergy, DRACMA) provides conditional formula recommendations and advises that these should be interpreted with special attention to patient preference, cost and clinical circumstance.",
"   </p>",
"   <p>",
"    Extensively hydrolyzed formula (eHF) is recommended over other hypoallergenic formulas (or soy formula) for the majority of patients with CMA, since more than 90 percent of infants with CMA tolerate extensively hydrolyzed milk protein-based infant formulas (",
"    <a class=\"graphic graphic_table graphicRef79377 \" href=\"UTD.htm?9/53/10075\">",
"     table 8",
"    </a>",
"    ). The DRACMA summary report recommends an amino acid based infant formula over an eHF in certain circumstances: for those infants with IgE-mediated CMA at high-risk of anaphylaxis, for any patient with eosinophilic esophagitis (EoE), and for those infants who continue to exhibit symptoms on eHFs [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/24\">",
"     24",
"    </a>",
"    ]. Both extensively hydrolyzed and amino acid based formulas are considered hypoallergenic [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/22\">",
"     22",
"    </a>",
"    ]. Partially hydrolyzed cow's milk formulas such as Good Start (Nestle) and Gentlease (Enfamil) are not considered hypoallergenic and are not suitable options for infants with CMA [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We recommend using an extensively hydrolyzed formula (eHF) over soy formula for infants with CMA. Although soy formula is tolerated by approximately 85 percent of infants with IgE-mediated CMA, the DRACMA summary report recommends that soy formula not be given to infants with CMA during the first six months of life [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/22\">",
"     22",
"    </a>",
"    ]. The prevalence of hypersensitivity to both soy and milk is up to 60 percent for infants with non-IgE mediated CMA, such as enterocolitis syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/22\">",
"     22",
"    </a>",
"    ]. Another caveat in selecting a soy formula for infants &lt;4 to 6 months of age with CMA is that soy is not considered a good choice for atopy prevention in infants at high risk for allergy. However, we generally do not switch infants with CMA to an eHF if they are already on a soy formula and tolerate it",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    if cost or taste preferences preclude the use of hypoallergenic formulas. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/37/25175?source=see_link&amp;anchor=H10#H10\">",
"     \"Introducing formula and solid foods to infants at risk for allergic disease\", section on 'Soy formula versus others'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/37/25175?source=see_link&amp;anchor=H11#H11\">",
"     \"Introducing formula and solid foods to infants at risk for allergic disease\", section on 'Conclusions for formula selection'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/52/34631?source=see_link\">",
"     \"Food protein-induced proctitis/colitis and enteropathy of infancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Children &gt;1 year old",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transitioning an infant from a complete formula to whole milk is typically considered around one year of age, usually around the time that at least two thirds of the total daily caloric intake comes from a varied solid food diet. However, other criteria must be considered in the food-allergic child, especially one with multiple food allergies, since a varied solid food diet may not be possible. Assessing the nutritional contribution of the solid food diet before transitioning from a formula to a milk substitute, as well as considering the nutritional benefits and pitfalls of the alternative milk, is strongly advised.",
"   </p>",
"   <p>",
"    Continued use of commercially prepared complete formulas beyond infancy is recommended for children with multiple food allergies on very limited diets or for those avoiding both milk and soy (",
"    <a class=\"graphic graphic_table graphicRef63667 \" href=\"UTD.htm?0/36/587\">",
"     table 9",
"    </a>",
"    ). Enriched alternative milk sources (usually soy or grain-based) generally do not provide comparable nutrition to whole cow's milk or formulas (",
"    <a class=\"graphic graphic_table graphicRef74819 \" href=\"UTD.htm?17/16/17676\">",
"     table 7",
"    </a>",
"    ). The DRACMA summary report recommends a CM substitute of adequate nutritional value (substitute formula or breast milk) until two years of age. The use of enriched alternative milks for children between one and two years of age is not recommended to the general population, but can be used on an individual basis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Enriched soy milk is an appropriate alternative for older toddlers, if tolerated, that provides dietary calcium, vitamin D, and protein sources similar to milk (",
"    <a class=\"graphic graphic_table graphicRef74819 \" href=\"UTD.htm?17/16/17676\">",
"     table 7",
"    </a>",
"    ). It is important to confirm that the child is consuming an enriched version, since unenriched alternative milk beverages (soy and rice) are available. There is at least one reported case of a patient with rickets due to consumption of an unenriched soy milk product [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/16\">",
"     16",
"    </a>",
"    ]. The risk of inadequate intake of calcium and vitamin D among children with CMA is decreased if a dairy-free enriched soy milk or commercially prepared hypoallergenic",
"    <span class=\"nowrap\">",
"     infant/toddler",
"    </span>",
"    formula is provided [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For children with concomitant milk and soy allergy, enriched oat \"milk\" provides calcium, vitamin D, vitamin B12, and phosphorus, but is lower in protein and fat (",
"    <a class=\"graphic graphic_table graphicRef74819 \" href=\"UTD.htm?17/16/17676\">",
"     table 7",
"    </a>",
"    ). Other grain (eg, rice) and nut (eg, almond) beverages tend to be even lower in fat and protein than oat beverage. Protein requirements should be met entirely through solid foods in the diet before switching to enriched alternative grain or nut beverages. Fat intake also needs to be assessed. Additional fat in the form of vegetable oils may be required. When the child is ready to transition to an enriched alternative grain or nut beverage, intake should be limited to the amount required to meet calcium needs.",
"   </p>",
"   <p>",
"    Most alternative mammalian milks, such as goat's or sheep's milk, are also not suitable. Up to 92 percent of individuals with cow's milk protein allergies will also react to goat's milk [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/22\">",
"     22",
"    </a>",
"    ]. Donkey's or mare's milk may be better tolerated in some cases, although these milks are generally not commercially available. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/63/2042?source=see_link\">",
"     \"Food allergens: Overview of clinical features and cross-reactivity\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29640?source=see_link\">",
"     \"Milk allergy: Clinical features and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/9/40087?source=see_link\">",
"     \"Milk allergy: Management\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Calcium fortified juices are often recommended to meet calcium needs. However, a one year old must drink 16 ounces per day of a highly fortified juice (30 percent of the Daily Value for",
"    <span class=\"nowrap\">",
"     calcium/serving)",
"    </span>",
"    to consume adequate calcium. Excessive intake of a nutritionally inferior milk substitute or juice may displace nutrients from other dietary sources resulting in subsequent deficiencies, particularly protein, fat, and energy.",
"   </p>",
"   <p>",
"    There are numerous other \"dairy-free\" products on the market, such as soy or coconut-based yogurt and soy or rice-based cheese. However, not all \"dairy-free\" products are milk protein free, therefore reading all ingredient labels is imperative. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/48/18185?source=see_link&amp;anchor=H6#H6\">",
"     \"Management of food allergy: Avoidance\", section on 'Food labeling'",
"    </a>",
"    .) As an example, casein is an ingredient in a rice cheese brand. Additionally, many of these products are manufactured on shared equipment with milk products and run the risk of cross contact with milk. It is possible to find some dairy-like products that are truly milk protein free and manufactured on dedicated equipment. The nutritional contribution of these foods should be evaluated, however, as they are not comparable to the milk versions. As an example, coconut yogurt is essentially protein free.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Wheat allergy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Wheat contributes carbohydrates, the major source of energy in the diet, as well as many micronutrients. Four servings of wheat-based products, such as whole grain and enriched cereals or breads, generally provide greater than 50 percent of the RDA for carbohydrate, iron, thiamine, riboflavin, and niacin for individuals one year of age and older, and are a significant source of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    , vitamin B6, and magnesium. Whole grain wheat products also contribute fiber to the diet. Alternative dietary sources of these macro and micronutrients should be provided when wheat is eliminated from the diet (",
"    <a class=\"graphic graphic_table graphicRef54072 \" href=\"UTD.htm?22/35/23099\">",
"     table 4",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The wheat allergic patient must avoid all wheat containing foods, resulting in the elimination of many processed and manufactured products including bread, cereal, pasta, crackers, cookies, and cakes. Wheat is also commonly used as a minor ingredient in other commercial food products, such as condiments and marinades, cold cuts, soups, soy sauce, some low or non-fat products, hard candies, licorice, and jelly beans.",
"   </p>",
"   <p>",
"    Many alternative flours are available to patients with wheat allergy, including rice, corn, oat, barley, buckwheat, rye, amaranth, millet, and quinoa. Twenty percent of individuals with one grain allergy may be clinically reactive to another grain [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/27\">",
"     27",
"    </a>",
"    ]. Thus, use of these alternative products should be individualized and based upon tolerance as determined by the patient's allergy specialist. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/63/2042?source=see_link\">",
"     \"Food allergens: Overview of clinical features and cross-reactivity\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Alternative grain flours may improve the nutritional quality, variety, and convenience of the wheat-restricted diet. Many of these flours are commercially available for home use. In addition, there are a wide variety of wheat-free and gluten-free products made from these flours. Choosing whole or enriched grains greatly improves the nutritional quality of the diet. One issue is that many of these flours are not fortified. A fortified infant cereal can be substituted for a portion of the alternative flour used in baked products to increase the amount of nutrients such as iron, thiamine, riboflavin, niacin, and zinc [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/47/7929?source=see_link\">",
"     \"Management of celiac disease in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/38/4714?source=see_link\">",
"     \"Management of celiac disease in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Egg allergy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eggs contribute protein, vitamin B12, riboflavin, pantothenic acid,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?9/25/9618?source=see_link\">",
"     biotin",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/37/13907?source=see_link\">",
"     selenium",
"    </a>",
"    in the diet. Many foods supply the nutrients found in eggs, including milk, soy, meats, fish, and poultry (",
"    <a class=\"graphic graphic_table graphicRef74067 \" href=\"UTD.htm?6/18/6443\">",
"     table 5",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Egg in the diet does not usually account for a large percentage of daily dietary intakes. Thus, egg avoidance is not likely to negatively impact nutritional intake. However, egg is a common ingredient in the Western diet; therefore, patients with egg allergy will need to learn how to replace egg in recipes (",
"    <a class=\"graphic graphic_table graphicRef62743 \" href=\"UTD.htm?1/62/2027\">",
"     table 10",
"    </a>",
"    ). Many commercial egg substitutes are not suitable for the egg allergic individual as they contain egg protein.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Soybean allergy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Soy is a nutritionally dense food containing protein, thiamine, riboflavin, pyridoxine,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    , calcium, phosphorus, magnesium, iron, and zinc. Soy generally does not appear in large quantities in the diet; therefore, the nutrients lost due to soy elimination may easily be replaced (",
"    <a class=\"graphic graphic_table graphicRef72372 \" href=\"UTD.htm?30/50/31531\">",
"     table 6",
"    </a>",
"    ). Exceptions to the minimal impact of soy elimination on nutritional status include concomitant milk allergy or other dietary patterns (such as vegetarianism) that limit food choices. In these cases, the diet should be carefully evaluated to ensure adequacy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/4/8266?source=see_link\">",
"     \"Vegetarian diets for children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Soy protein is found in a large assortment of products, including baked goods, cereals, crackers, canned tuna and soups, reduced-fat peanut butter, pre-basted meat products, cold cuts, hot dogs, and many vegetarian-based products. Eliminating soy from the diet limits the variety of manufactured products that have diverse nutritional and social benefits. Studies show that the vast majority of individuals with soy allergy can tolerate highly refined soy oil and soy lecithin [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7993/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. Soy oil and soy lecithin are present in many processed or manufactured foods and avoidance of these two soy-derived ingredients may unnecessarily eliminate an extensive list of products.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Peanut, tree nut, fish, and shellfish allergies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Peanut, tree nut, fish, and shellfish allergies are the most common food allergens in adults. Although these foods contain valuable nutrients, they do not usually account for a large percentage of daily dietary intakes. Many foods supply the nutrients found in these foods and substitutions can easily be made when the allergy stands alone. However, meeting dietary needs may be more difficult when multiple food allergies occur or the diet is restricted for other reasons (eg, vegetarian diet). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/61/16346?source=see_link\">",
"     \"Seafood allergies: Fish and shellfish\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/63/2042?source=see_link\">",
"     \"Food allergens: Overview of clinical features and cross-reactivity\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/4/8266?source=see_link\">",
"     \"Vegetarian diets for children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?34/35/35379?source=see_link\">",
"       \"Patient information: Food allergy treatment and avoidance (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The goals of nutritional intervention in patients with food allergy are to prevent allergic reactions through allergen elimination and to ensure adequate nutrition within the context of the allergen-restricted diet. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      To avoid nutritional deficiencies, patients with food allergies should be referred to a registered dietitian familiar with food allergies. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'General nutrition and food allergy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Dietary limitations due to food allergy can lead to deficits in total energy, macronutrients (protein, fat, carbohydrates), and micronutrients (vitamins, minerals, trace elements). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Energy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Protein'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Fat'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7\">",
"       'Carbohydrate'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Micronutrients'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children with food allergies are at greater risk of negative nutritional impact from food allergies. Their growth and development should be monitored closely. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Monitoring growth'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Measures that are essential to preventing inadequate growth and suboptimal nutrition include recommending nutrient dense alternatives to the eliminated food at the time of diagnosis and following up to ensure that the alternative food is accepted and incorporated into the diet. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Food elimination diets'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Alternative dietary sources are available for milk (",
"      <a class=\"graphic graphic_table graphicRef74819 \" href=\"UTD.htm?17/16/17676\">",
"       table 7",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef55081 \" href=\"UTD.htm?29/52/30539\">",
"       table 3",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef79377 \" href=\"UTD.htm?9/53/10075\">",
"       table 8",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef63667 \" href=\"UTD.htm?0/36/587\">",
"       table 9",
"      </a>",
"      ), wheat (",
"      <a class=\"graphic graphic_table graphicRef54072 \" href=\"UTD.htm?22/35/23099\">",
"       table 4",
"      </a>",
"      ), egg (",
"      <a class=\"graphic graphic_table graphicRef74067 \" href=\"UTD.htm?6/18/6443\">",
"       table 5",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef62743 \" href=\"UTD.htm?1/62/2027\">",
"       table 10",
"      </a>",
"      ), and soy (",
"      <a class=\"graphic graphic_table graphicRef72372 \" href=\"UTD.htm?30/50/31531\">",
"       table 6",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Cow's milk allergy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H15\">",
"       'Wheat allergy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H16\">",
"       'Egg allergy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H17\">",
"       'Soybean allergy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7993/abstract/1\">",
"      Christie L, Hine RJ, Parker JG, Burks W. Food allergies in children affect nutrient intake and growth. J Am Diet Assoc 2002; 102:1648.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7993/abstract/2\">",
"      Henriksen C, Eggesb&oslash; M, Halvorsen R, Botten G. Nutrient intake among two-year-old children on cows' milk-restricted diets. Acta Paediatr 2000; 89:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7993/abstract/3\">",
"      Santangelo CM, McCloud E. Nutritional management of children who have food allergies and eosinophilic esophagitis. Immunol Allergy Clin North Am 2009; 29:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7993/abstract/4\">",
"      Chehade M, Sampson HA. Epidemiology and etiology of eosinophilic esophagitis. Gastrointest Endosc Clin N Am 2008; 18:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7993/abstract/5\">",
"      Mofidi S. Nutritional management of pediatric food hypersensitivity. Pediatrics 2003; 111:1645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7993/abstract/6\">",
"      Trumbo P, Schlicker S, Yates AA, et al. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. J Am Diet Assoc 2002; 102:1621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7993/abstract/7\">",
"      Liu T, Howard RM, Mancini AJ, et al. Kwashiorkor in the United States: fad diets, perceived and true milk allergy, and nutritional ignorance. Arch Dermatol 2001; 137:630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7993/abstract/8\">",
"      Isolauri E, S&uuml;tas Y, Salo MK, et al. Elimination diet in cow's milk allergy: risk for impaired growth in young children. J Pediatr 1998; 132:1004.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7993/abstract/9\">",
"      Jensen VB, J&oslash;rgensen IM, Rasmussen KB, et al. Bone mineral status in children with cow milk allergy. Pediatr Allergy Immunol 2004; 15:562.",
"     </a>",
"    </li>",
"    <li>",
"     Agency for Healthcare Research and Quality. Effects of omega-3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythmatosus, and osteoporosis. Evidence Report/Technology Assessment no. 89 (Prepared by Southern California/RAND Evidence-based Practise Center, under contract no. 290-02-0003). AHRQ publication no. 04-E012-2, Rockville, MD March 2004.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7993/abstract/11\">",
"      James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 2000; 71:343S.",
"     </a>",
"    </li>",
"    <li>",
"     Dietary Reference Intakes (DRI) tables. file://fnic.nal.usda.gov/nal_display/index.php?info_center=4&amp;tax_level=3&amp;tax_subject=256&amp;topic_id=1342&amp;level3_id=5140 (Accessed on September 24, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7993/abstract/13\">",
"      Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11 2002; :1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7993/abstract/14\">",
"      NIAID-Sponsored Expert Panel, Boyce JA, Assa'ad A, et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol 2010; 126:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7993/abstract/15\">",
"      Salman S, Christie L, Burks W, Mccabe-Sellers B. Dietary intakes of children with food allergies: comparison of the food guide pyramid and the recommended dietary allowances, 10th ed. J Allergy Clin Immunol 2002; 109:S214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7993/abstract/16\">",
"      Carvalho NF, Kenney RD, Carrington PH, Hall DE. Severe nutritional deficiencies in toddlers resulting from health food milk alternatives. Pediatrics 2001; 107:E46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7993/abstract/17\">",
"      Noimark L, Cox HE. Nutritional problems related to food allergy in childhood. Pediatr Allergy Immunol 2008; 19:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7993/abstract/18\">",
"      Yu JW, Pekeles G, Legault L, McCusker CT. Milk allergy and vitamin D deficiency rickets: a common disorder associated with an uncommon disease. Ann Allergy Asthma Immunol 2006; 96:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7993/abstract/19\">",
"      Fox AT, Du Toit G, Lang A, Lack G. Food allergy as a risk factor for nutritional rickets. Pediatr Allergy Immunol 2004; 15:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7993/abstract/20\">",
"      Sampson HA. Update on food allergy. J Allergy Clin Immunol 2004; 113:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7993/abstract/21\">",
"      Sicherer SH, Sampson HA. 9. Food allergy. J Allergy Clin Immunol 2006; 117:S470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7993/abstract/22\">",
"      American Academy of Pediatrics. Committee on Nutrition. Hypoallergenic infant formulas. Pediatrics 2000; 106:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7993/abstract/23\">",
"      Mannion CA, Gray-Donald K, Johnson-Down L, Koski KG. Lactating women restricting milk are low on select nutrients. J Am Coll Nutr 2007; 26:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7993/abstract/24\">",
"      Fiocchi A, Sch&uuml;nemann HJ, Brozek J, et al. Diagnosis and Rationale for Action Against Cow's Milk Allergy (DRACMA): a summary report. J Allergy Clin Immunol 2010; 126:1119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7993/abstract/25\">",
"      Olafsdottir AS, Wagner KH, Thorsdottir I, Elmadfa I. Fat-soluble vitamins in the maternal diet, influence of cod liver oil supplementation and impact of the maternal diet on human milk composition. Ann Nutr Metab 2001; 45:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7993/abstract/26\">",
"      Butte NF, Calloway DH. Evaluation of lactational performance of Navajo women. Am J Clin Nutr 1981; 34:2210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7993/abstract/27\">",
"      Sicherer SH. Clinical implications of cross-reactive food allergens. J Allergy Clin Immunol 2001; 108:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7993/abstract/28\">",
"      Taylor SL, Hefle SL, Bindslev-Jensen C, et al. Factors affecting the determination of threshold doses for allergenic foods: how much is too much? J Allergy Clin Immunol 2002; 109:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7993/abstract/29\">",
"      Crevel RW, Kerkhoff MA, Koning MM. Allergenicity of refined vegetable oils. Food Chem Toxicol 2000; 38:385.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2388 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-210.101.131.232-C3EBFED581-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_51_7993=[""].join("\n");
var outline_f7_51_7993=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GENERAL NUTRITION AND FOOD ALLERGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Energy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Protein",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Fat",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Replacement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Carbohydrate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Micronutrients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      MONITORING GROWTH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      FOOD ELIMINATION DIETS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Cow's milk allergy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Breastfed infants",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Formula fed infants",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Children &gt;1 year old",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Wheat allergy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Egg allergy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Soybean allergy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Peanut, tree nut, fish, and shellfish allergies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/2388\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/2388|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?7/1/7198\" title=\"figure 1\">",
"      Fat content of oils",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/2388|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?15/26/15787\" title=\"table 1\">",
"      AMDR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/42/18091\" title=\"table 2\">",
"      Sources dietary fat",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/52/30539\" title=\"table 3\">",
"      Dietary alternatives to milk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/35/23099\" title=\"table 4\">",
"      Wheat alternatives",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?6/18/6443\" title=\"table 5\">",
"      Egg alternatives",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?30/50/31531\" title=\"table 6\">",
"      Soy alternatives",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/16/17676\" title=\"table 7\">",
"      Nutritional comparison of milk to alternative sources",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/53/10075\" title=\"table 8\">",
"      Infant hypoallergenic formula",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/36/587\" title=\"table 9\">",
"      Toddler hypoallergenic formulas",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/62/2027\" title=\"table 10\">",
"      Egg substitutes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/18/10537?source=related_link\">",
"      Causes of short stature",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/60/18376?source=related_link\">",
"      Diagnostic approach to short stature",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/12/5321?source=related_link\">",
"      Diagnostic evaluation of food allergy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/40/23175?source=related_link\">",
"      Dietary and nutritional assessment in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/34/2601?source=related_link\">",
"      Dietary fat",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/61/28631?source=related_link\">",
"      Dietary history and recommended dietary intake in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/0/18441?source=related_link\">",
"      Dietary recommendations for toddlers, preschool, and school-age children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/12/14538?source=related_link\">",
"      Etiology and evaluation of failure to thrive (undernutrition) in children younger than two years",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/63/2042?source=related_link\">",
"      Food allergens: Overview of clinical features and cross-reactivity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/52/34631?source=related_link\">",
"      Food protein-induced proctitis/colitis and enteropathy of infancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/17/26904?source=related_link\">",
"      History and physical examination in the patient with possible food allergy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/40/36487?source=related_link\">",
"      Indications for nutritional assessment in childhood",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/37/25175?source=related_link\">",
"      Introducing formula and solid foods to infants at risk for allergic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/43/10938?source=related_link\">",
"      Introducing solid foods and vitamin and mineral supplementation during infancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/55/22391?source=related_link\">",
"      Laboratory and radiologic evaluation of nutritional status in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/31/32248?source=related_link\">",
"      Malnutrition in developing countries: Clinical assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/38/4714?source=related_link\">",
"      Management of celiac disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/47/7929?source=related_link\">",
"      Management of celiac disease in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/48/18185?source=related_link\">",
"      Management of food allergy: Avoidance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/53/43864?source=related_link\">",
"      Maternal nutrition during lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/14/31976?source=related_link\">",
"      Measurement of growth in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/4/38983?source=related_link\">",
"      Micronutrient deficiencies associated with malnutrition in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29640?source=related_link\">",
"      Milk allergy: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/9/40087?source=related_link\">",
"      Milk allergy: Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42633?source=related_link\">",
"      Normal growth patterns in infants and prepubertal children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/45/32474?source=related_link\">",
"      Pathogenesis, clinical manifestations, and diagnosis of eosinophilic esophagitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?34/35/35379?source=related_link\">",
"      Patient information: Food allergy treatment and avoidance (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/21/38233?source=related_link\">",
"      Poor weight gain in children older than two years of age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/61/16346?source=related_link\">",
"      Seafood allergies: Fish and shellfish",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/30/19943?source=related_link\">",
"      The pediatric physical examination: General principles and standard measurements",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/4/8266?source=related_link\">",
"      Vegetarian diets for children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/38/28266?source=related_link\">",
"      Vitamin D insufficiency and deficiency in children and adolescents",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_51_7994="Stings of imported fire ants: Clinical manifestations, diagnosis, and treatment";
var content_f7_51_7994=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Stings of imported fire ants: Clinical manifestations, diagnosis, and treatment",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/51/7994/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/51/7994/contributors\">",
"     Richard D deShazo, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/51/7994/contributors\">",
"     David F Williams, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/51/7994/contributors\">",
"     Jerome Goddard, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/51/7994/contributors\">",
"     Robin Rockhold, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/51/7994/contributors\">",
"     Stephen F Kemp, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/51/7994/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/51/7994/contributors\">",
"     David B Golden, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/51/7994/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/51/7994/contributors\">",
"     Anna M Feldweg, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?7/51/7994/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 8, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Imported fire ants (IFAs) are aggressive, venomous ants that sting with little provocation and are difficult to avoid in endemic areas. Their venom causes painful local reactions and induces a high rate of allergic sensitization. Patients who become allergic to IFA venom can experience a range of reactions, including life-threatening anaphylaxis.",
"   </p>",
"   <p>",
"    The term imported fire ant refers to two members of the Solenopsis species [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The red imported fire ant (RIFA), Solenopsis invicta",
"     </li>",
"     <li>",
"      The black imported fire ant (BIFA), Solenopsis richteri",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This topic review discusses the medical consequences of IFA stings and the treatment of IFA venom allergy. The entomology of IFAs and the chemical and biological control of these pests are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/36/7752?source=see_link\">",
"     \"Entomology and control of imported fire ants\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TERRITORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Regularly updated maps of the fire ant range and agriculture quarantine areas within the United States are available online at",
"    <a class=\"external\" href=\"file://www.aphis.usda.gov/plant_health/plant_pest_info/fireants/downloads/fireant.pdf\">",
"     www.aphis.usda.gov/plant_health/plant_pest_info/fireants/downloads/fireant.pdf",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Red imported fire ants",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the United States, the RIFA is the most abundant, widespread, and damaging species. The RIFA is currently found in 14 states (Alabama, Arkansas, California, Florida, Georgia, Louisiana, Mississippi, New Mexico, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, and Virginia) with limited territory in Arizona, Maryland, and Delaware [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Infestations also occur in Mexico [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/3\">",
"     3",
"    </a>",
"    ], as well as several Caribbean islands including Puerto Rico, the Bahamas, the British and US Virgin Islands, Antigua, and Trinidad. In addition, RIFAs have been detected in Australia, New Zealand, Taiwan, and China [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Black imported fire ants",
"    </span>",
"    &nbsp;&mdash;&nbsp;The habitat of the BIFA is relatively limited to a small area of North Alabama, North Mississippi, and South Tennessee.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H496031\">",
"    <span class=\"h1\">",
"     APPEARANCE AND BEHAVIORS OF IFA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Worker ants vary in size from one-eighth to one-fourth inch (three to six mm) long and are reddish brown to black in color. They all have stingers (",
"    <a class=\"graphic graphic_figure graphicRef73265 \" href=\"UTD.htm?7/44/7873\">",
"     figure 1",
"    </a>",
"    ) and will attack anything that disturbs them. A single ant can deliver multiple stings.",
"   </p>",
"   <p>",
"    Fire ants are difficult to avoid in endemic areas. Stings of IFAs can be sustained both outdoors and indoors. Available data suggest that 50 to 89 percent of people residing in an IFA-infested area will be stung each year. In one report, 51 percent of 107 previously unexposed subjects were stung within three weeks of arrival in an endemic area [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Children are stung more often than adults. Patients in long-term care facilities are also at risk, as they may not be aware of their surroundings and may be immobilized by disease or otherwise unable to respond if they come into contact with ants.",
"   </p>",
"   <p>",
"    When their nests are disturbed, IFAs swarm out and sting anything they encounter, including humans, pets, livestock, and wildlife [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/2\">",
"     2",
"    </a>",
"    ]. Once foraging fire ants have made contact with a potential victim, a variety of stimuli, including simple movement of the patient, may trigger a stinging event, leading to multiple stings in a very short period of time.",
"   </p>",
"   <p>",
"    Stings occur most frequently during summer, most commonly in children, and typically on the lower extremities. Off-season stings (eg, during winter months) often do not cause as much pain and may go unnoticed until the local reaction develops. This may reflect seasonal differences in IFA venom [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H498148\">",
"     'Protein allergens'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    During a sting, the ant uses its powerful mandibles to hold onto the skin, arches its body, and injects venom through the stinger located at the tip of its abdomen (",
"    <a class=\"graphic graphic_picture graphicRef56561 \" href=\"UTD.htm?42/2/43042\">",
"     picture 1",
"    </a>",
"    ). The ant will sting repeatedly if not quickly removed, and often leaves a circular pattern of stings as it rotates its body. The human victim characteristically experiences an immediate, intense burning (the \"fire\" inspiring the name of the ant) and itching at the sting site.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H500021\">",
"    <span class=\"h2\">",
"     Fire ant avoidance",
"    </span>",
"    &nbsp;&mdash;&nbsp;IFAs will not sting through fabric, stockings, or tights [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/8\">",
"     8",
"    </a>",
"    ]. Thus, wearing shoes (not sandals) with socks and long pants are helpful avoidance measures. Hands and arms should be covered with gloves and sleeves when gardening or doing outdoor work. Available insect repellents are",
"    <strong>",
"     not",
"    </strong>",
"    effective [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/8\">",
"     8",
"    </a>",
"    ]. When a sting sensation is noted, the ant should be quickly killed with a slap to prevent multiple stings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H498141\">",
"    <span class=\"h1\">",
"     VENOM",
"    </span>",
"    &nbsp;&mdash;&nbsp;The venom of IFAs is approximately 95 percent water-insoluble alkaloids by volume, with the remaining 5 percent being an aqueous solution of proteins. This differs markedly from the venoms of yellow jackets, hornets, wasps, and bees, which are largely aqueous protein solutions. The alkaloids cause the sterile pustule, but are not allergenic. (See",
"    <a class=\"local\" href=\"#H498170\">",
"     'Venom alkaloids'",
"    </a>",
"    below.) The allergenic portion of the venom is the protein component [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H498148\">",
"     'Protein allergens'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The volume of injectate positively correlates with body size in S. invicta. Direct measurements suggest that the venom volume delivered per sting from a S. invicta worker is approximately 0.66 nanoliters, containing 0.56 mcg of venom alkaloid and 10 to 100 nanograms of protein [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H498148\">",
"    <span class=\"h2\">",
"     Protein allergens",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are seasonal variations in the protein content of the IFA venom, with higher protein levels in summer than at other times [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/7\">",
"     7",
"    </a>",
"    ]. Solenopsis invicta (RIFA) venom has four dominant allergenic proteins, Sol i 1, Sol i 2, Sol i 3, and Sol i 4 (",
"    <a class=\"graphic graphic_table graphicRef55585 \" href=\"UTD.htm?29/48/30475\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sol i 1, which has a molecular weight of 37 kD, comprises about 2 to 4 percent of venom allergen by weight and possesses both phospholipase A and B activities [",
"      <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/11\">",
"       11",
"      </a>",
"      ]. Some of the N-terminal sequences of Sol i 1 share sequences with the venom phospholipase of Vespula maculifrons, and sera from some patients with allergy to vespid venom contain IgE, which binds to Sol i 1 by RAST (radioallergosorbent test) or immunoblot studies [",
"      <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/10,12,13\">",
"       10,12,13",
"      </a>",
"      ]. The close structural similarity of portions of the Sol i 1 molecule to portions of vespid phospholipase may explain this immunologic cross-reactivity.",
"      <br/>",
"      <br/>",
"      Little is known about the clinical significance of the immunologic cross-reactivity between fire ant and vespid venom. However, it could explain the rare occurrence of anaphylaxis to the first recognized fire ant sting in isolated patients with existing allergy to vespid stings.",
"     </li>",
"     <li>",
"      Sol i 2 comprises one-half to two-thirds of all venom protein [",
"      <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/11,14\">",
"       11,14",
"      </a>",
"      ]. No other proteins of similar structure have been found in the Protein Identification Resource or Swiss-Prot databases.",
"     </li>",
"     <li>",
"      Sol i 3 is a single chain molecule consisting of 212 amino acids that comprises approximately 15 to 25 percent of total venom protein that has almost 50 percent identity with vespid antigen 5 [",
"      <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/11\">",
"       11",
"      </a>",
"      ]. However, it lacks immunologic cross-reactivity with vespid antigen 5 [",
"      <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/13\">",
"       13",
"      </a>",
"      ]. Its cDNA has been successfully cloned.",
"     </li>",
"     <li>",
"      Sol i 4 is a single chain 117-amino acid protein of molecular weight 13,340 and comprises between 8 and 10 percent of venom protein content [",
"      <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/11\">",
"       11",
"      </a>",
"      ]. Although it shares about 35 percent identity with Sol i 2, it lacks immunologic cross-reactivity. Sol i 2 and 4 are unrelated to any proteins found in venoms from other insect genera [",
"      <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Solenopsis richteri (BIFA) venom contains proteins designated as Sol r 1, 2, and 3 which are chemically and antigenically very similar to Sol i 1, 2, and 3. A protein corresponding to Sol i 4 has not been found in Solenopsis richteri venom (",
"    <a class=\"graphic graphic_table graphicRef55585 \" href=\"UTD.htm?29/48/30475\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H498170\">",
"    <span class=\"h2\">",
"     Venom alkaloids",
"    </span>",
"    &nbsp;&mdash;&nbsp;The alkaloids in IFA venom are toxic to human epithelium and induce a sterile pustule at the sting site. These compounds are alkaline 2-methyl-6-n-alkyl and alkenyl piperidines [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/6,15-17\">",
"     6,15-17",
"    </a>",
"    ], and are classified as solenopsins and dehydrosolenopsins [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. Venom alkaloids have hemolytic, cytotoxic, and antibacterial properties [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/20-24\">",
"     20-24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    S. invicta (RIFA) workers produce the most complex and toxic venom alkaloids of any of the North American Solenopsis species [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/25\">",
"     25",
"    </a>",
"    ]. The relative composition of fire ant venom alkaloids varies with the size and age of the individual worker ant, as well as between species and among castes within a species [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/17,18,26\">",
"     17,18,26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Venom alkaloids have various other properties. In animal and human studies, these include activation of platelets, neutrophils, and the alternate complement pathway, histamine release from peritoneal mast cells, irreversible inhibition of neuromuscular transmission, and inhibition of nitric oxide synthase [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/25,27-31\">",
"     25,27-31",
"    </a>",
"    ]. Direct convulsant, cardiotoxic, and respiratory depressant actions of two synthetic venom alkaloids, solenopsin A and isosolenopsin A, have been demonstrated in rodents [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The data reviewed in the above section indicates that substantial pharmacological activity is present in the alkaloid fraction of S. invicta venom. However, direct, nonallergic, toxic effects resulting from S. invicta envenomation in humans have not been reported. Although human systemic toxicity has not been convincingly demonstrated, the substantial pharmacologic activity of IFA venom alkaloids may underlie the poor clinical outcome seen in some cases of massive attacks.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7806077\">",
"    <span class=\"h2\">",
"     Cross-reactivity with other Hymenoptera species",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cross-reactivity between antigens in IFA venom and antigens in the venoms of other Hymenoptera species is limited [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/13,33\">",
"     13,33",
"    </a>",
"    ]. Thus, if a patient was able to identify an IFA as the insect which caused a reaction, there is no need to also evaluate the patient for allergy to other Hymenoptera species.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H499132\">",
"    <span class=\"h1\">",
"     CLINICAL REACTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical reactions to IFA stings can range from mild discomfort to life-threatening anaphylaxis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H499191\">",
"    <span class=\"h2\">",
"     Local reactions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Local reactions are divided into three types, the wheal and flare reaction, the sterile pustule, and the large local reaction. By definition, local reactions involve signs and symptoms at or contiguous with the sting site.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Wheal and flare",
"      </strong>",
"      &mdash; Nearly all individuals stung by IFAs develop hive-like lesions with surrounding erythema at the sting site. This reaction develops within 20 minutes and is accompanied by burning and then pruritus (",
"      <a class=\"graphic graphic_picture graphicRef56561 \" href=\"UTD.htm?42/2/43042\">",
"       picture 1",
"      </a>",
"      ). The burning sensation is characteristic and helps differentiate the stings of IFA from those of other insects. Symptoms are more pronounced during the summer months when the ants have more venom. The initial symptoms are followed in the succeeding 24 hours by development of the sterile pustule.",
"     </li>",
"     <li>",
"      <strong>",
"       Sterile pustule",
"      </strong>",
"      &mdash; A sterile pustule filled with yellow fluid containing epithelial debris and few cells develops at the site of a sting within the first 24 hours. This is relatively pathognomonic for the sting of the IFA (",
"      <a class=\"graphic graphic_picture graphicRef76841 \" href=\"UTD.htm?18/52/19264\">",
"       picture 2",
"      </a>",
"      ) and is caused by the venom alkaloids. The sterile pustule peaks in size at 24 hours and can last for a week or more. The epidermis overlying the pustule usually remains intact for 48 to 72 hours before it erodes, which generally allows sufficient time for new epidermis to cover the base of the lesion.",
"     </li>",
"     <li>",
"      <strong>",
"       Large local reaction",
"      </strong>",
"      &mdash; In individuals with venom-specific IgE, large local reactions may develop at the sting site over 6 to 24 hours, simultaneously with the development of the sterile pustule. The pustule ultimately sits atop an area of intensely pruritic, painful inflammation (",
"      <a class=\"graphic graphic_picture graphicRef56561 \" href=\"UTD.htm?42/2/43042\">",
"       picture 1",
"      </a>",
"      ). Although usually self-limited, swelling can be severe and vascular compromise can occur in extremities. This review will refer to severe large local reactions as \"extreme local reactions.\" Extensive and spreading edema can be a source of confusion in extreme local reactions. However, by definition, the swelling is contiguous with the site of the sting.",
"      <br/>",
"      <br/>",
"      Histopathologic studies have demonstrated that large local reactions are IgE-mediated late cutaneous allergic reactions like those that can occur after stings of flying hymenoptera. On histologic examination, the lesions are composed of a dense fibrin gel and a mixed cellular infiltrate of eosinophils, neutrophils, and lymphocytes [",
"      <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H499216\">",
"    <span class=\"h2\">",
"     Systemic allergic reactions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systemic allergic reactions may range from cutaneous (generalized urticaria, angioedema, pruritus, erythema) to life-threatening bronchospasm, laryngeal edema, or vascular collapse (",
"    <a class=\"graphic graphic_table graphicRef79448 \" href=\"UTD.htm?19/49/20251\">",
"     table 2",
"    </a>",
"    ). Anaphylaxis may occur within minutes or may rarely develop hours after a sting. A single sting is sufficient to cause anaphylaxis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/35\">",
"     35",
"    </a>",
"    ]. Pathognomonic pustules can later identify the fire ant as the culprit.",
"   </p>",
"   <p>",
"    Reliable estimates for the incidence of fire ant anaphylaxis are not available because anaphylaxis is not a reportable disease. Published studies have reported rates ranging from 0.6 to 16 percent of those stung [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/36-38\">",
"     36-38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    IFA stings represent a leading cause of anaphylaxis for populations residing in endemic areas [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/39-41\">",
"     39-41",
"    </a>",
"    ]. One blinded survey of random adult blood donors in an IFA-endemic area demonstrated allergen-specific IgE to imported fire ant in the reference population was 1.7 times more common than IgE for other allergens associated with fatal allergic reactions [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Anaphylactic reactions to IFA stings usually occur in individuals who have been stung at least once before without eliciting anaphylaxis. However, some subjects have had anaphylactic reactions in response to their first stings [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/10\">",
"     10",
"    </a>",
"    ]. Clinical and laboratory studies suggest that most of these subjects have been sensitized previously to Vespula (yellow jacket) venom [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/10\">",
"     10",
"    </a>",
"    ]. Vespula venom cross-reacts with Solenopsis venom in vitro. There is also evidence that the venom of the common striped scorpion, Centruroides vittatus, may be cross-reactive with IFA venom, and that this may be responsible for reported episodes of anaphylaxis upon an initial scorpion sting [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H499243\">",
"    <span class=\"h2\">",
"     Toxic reactions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conditions that have been associated with fire ant stings in humans include serum sickness, nephrotic syndrome, seizures, mononeuritis, and worsening of preexisting cardiopulmonary disease [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/34,43-45\">",
"     34,43-45",
"    </a>",
"    ]. The pathogenesis of these sequelae is unclear.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H499271\">",
"    <span class=\"h3\">",
"     Massive attacks",
"    </span>",
"    &nbsp;&mdash;&nbsp;Massive attacks by foraging fire ants have been increasingly reported in the medical literature and the lay press [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/46\">",
"     46",
"    </a>",
"    ]. These attacks usually occur in the late summer months, and frequently after it rains. Victims can be found in the early morning hours covered with ants. Massive attacks can occur indoors and generally affect debilitated or very young patients who cannot ward off the attack. Individuals can sustain hundreds to thousands of fire ant stings.",
"   </p>",
"   <p>",
"    The reason for these massive attacks is unclear. Our group has hypothesized that IFA attacks on humans reflect normal foraging predatory behavior of the ants during periods of food scarcity, behavior that may reflect the increasing density of the ants in the environment. Examples of this behavior exist in the field. A Texas study reported 19 percent of cotton rats captured in traps in fire ant endemic areas were attacked by ants within a few hours [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/47\">",
"     47",
"    </a>",
"    ]. Over one-half of the attacked rats were found dead or partially eaten.",
"   </p>",
"   <p>",
"    It is unclear whether massive attacks can result in morbidity secondary to relatively large doses of venom components. Such toxic reactions following 50 to 100 simultaneous stings by winged hymenoptera species (bees, wasps, yellow jackets, and hornets) have been reported in humans, but equivalent reactions resulting from fire ant stings are not well-established. However, such reactions have been observed in small animals, such as dogs, rats, mice, and calves.",
"   </p>",
"   <p>",
"    Variable clinical outcomes in humans occur after massive fire ant attacks. Some patients recover without sequelae [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/48,49\">",
"     48,49",
"    </a>",
"    ]. In contrast, a five-day-old infant stung at home had a near fatal response, and the death of a three-month-old infant subsequent to numerous fire ant stings in a home in Phoenix, Arizona was reported [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several cases of massive fire ant attacks within health care facilities have now been reported. Of the six patients included in one report, only one fared well [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/49\">",
"     49",
"    </a>",
"    ]. That patient was in good general health except for Alzheimer disease and had no obvious untoward effects. In contrast, four of the six patients died within one week of the attack; two had worsening of preexisting cardiopulmonary insufficiency, one developed acute respiratory distress syndrome, and one had a cardiopulmonary arrest. The fifth patient, already bedbound with multiple health problems including severe heart failure, had progressive deterioration and died 13 months later.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10543224\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR REFERRAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients with systemic allergic reactions should be referred to an allergy expert for further evaluation. Patients with extreme local reactions should also be referred to an allergy expert, since testing for venom-specific IgE may be indicated. (See",
"    <a class=\"local\" href=\"#H23\">",
"     'Management of local reactions'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of local reactions is based upon clinical signs and symptoms. The diagnosis of systemic allergic reactions requires specific testing for IgE antibodies specific to IFA venom.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Local reactions",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of the various types of local reactions is clinical. The sterile pustule is relatively pathognomonic for the sting of the IFA (",
"    <a class=\"graphic graphic_picture graphicRef56561 \" href=\"UTD.htm?42/2/43042\">",
"     picture 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef76841 \" href=\"UTD.htm?18/52/19264\">",
"     picture 2",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H499132\">",
"     'Clinical reactions'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Systemic allergic reactions: testing for IFA venom allergy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who have experienced a",
"    <span class=\"nowrap\">",
"     systemic/anaphylactic",
"    </span>",
"    reaction in the recent past should be examined for the development or presence of sterile pustules, as these lesions are an important clue that an IFA sting was responsible. On rare occasions, pustules are absent.",
"   </p>",
"   <p>",
"    The diagnosis of IFA venom allergy requires the demonstration of venom-specific IgE (V-IgE) by skin testing or in vitro tests, in combination with a consistent clinical history. As with all forms of allergy, the presence of V-IgE alone does",
"    <strong>",
"     not",
"    </strong>",
"    predict systemic reactivity. For this reason, subjects",
"    <strong>",
"     without",
"    </strong>",
"    a history of systemic reactions to IFA stings should not be tested for V-IgE, as there is a high rate of asymptomatic production of V-IgE in populations exposed to fire ants. In studies of skin test reactivity to IFAs, positive skin tests were seen in up to 30 to 40 percent of history-negative control subjects [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/1,2,4,5\">",
"     1,2,4,5",
"    </a>",
"    ]. Similarly, the level of V-IgE does not predict the severity of a sting reaction in those with systemic allergy, and patients with large local reactions may have equally high levels of V-IgE.",
"   </p>",
"   <p>",
"    Skin testing is the preferred method of detecting V-IgE. Skin testing should only be performed by an allergy expert, both because of the skill required for interpretation and the potential risk of severe reactions in highly sensitive patients. It is general practice to allow at least six weeks to elapse between a reaction and IFA skin testing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10543325\">",
"    <span class=\"h3\">",
"     Laboratory studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest obtaining a baseline tryptase level to exclude underlying mast cell disorders in patients who have had hypotension with stings. Any elevation in baseline tryptase should be evaluated further. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/13/18650?source=see_link\">",
"     \"Evaluation and diagnosis of mastocytosis (cutaneous and systemic)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Skin testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Whole body extracts (WBE) are commercially available for skin testing as well as for use in immunotherapy. To be useful, these preparations must contain adequate amounts of venom proteins, but this has not been consistently true in the United States in the past. US manufacturers have since agreed to verify the content of Sol i 2 and Sol i 3 in their products. Despite these measures, we recommend confirming the venom content in extracts by skin testing an individual known to be skin test positive [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/9\">",
"     9",
"    </a>",
"    ]. We test all extracts on a volunteer with a history of large local reactions before using the extract in skin testing or immunotherapy.",
"   </p>",
"   <p>",
"    Whole body extracts are available as 1:10",
"    <span class=\"nowrap\">",
"     weight/volume",
"    </span>",
"    stock solutions. We use WBE from the more widespread species, the RIFA, for testing and immunotherapy in all patients, as there is extensive cross-reactivity between the two species. We recommend that the 1:10",
"    <span class=\"nowrap\">",
"     weight/volume",
"    </span>",
"    stock solutions be diluted 10-fold (to 1:100",
"    <span class=\"nowrap\">",
"     weight/volume)",
"    </span>",
"    and used for epicutaneous",
"    <span class=\"nowrap\">",
"     (prick/puncture)",
"    </span>",
"    testing. If the patient has had a severe anaphylactic reaction, further dilution for the first",
"    <span class=\"nowrap\">",
"     prick/puncture",
"    </span>",
"    test may be prudent.",
"   </p>",
"   <p>",
"    If prick testing is negative, intradermal testing is then performed. For intradermal testing, we start at 1:1,000,000",
"    <span class=\"nowrap\">",
"     weight/volume",
"    </span>",
"    and increase 10-fold until 1:500 to 1:1000",
"    <span class=\"nowrap\">",
"     weight/volume",
"    </span>",
"    is reached, or a positive result is obtained [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/51,52\">",
"     51,52",
"    </a>",
"    ]. One center reported that 9.5 percent of patients undergoing skin testing to IFA venom developed systemic allergic reactions, which is higher than the reported rates (2 to 4 percent) with other types of allergens, including other Hymenoptera venoms [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Skin testing with fire ant WBE is considered diagnostic for the presence of venom-specific IgE with a positive reaction (ie, a wheal measuring at least 3 mm greater than the negative control) at a concentration of 1:500",
"    <span class=\"nowrap\">",
"     weight/volume",
"    </span>",
"    or lower [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/52\">",
"     52",
"    </a>",
"    ]. A general discussion of the techniques of skin testing is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32633?source=see_link\">",
"     \"Overview of skin testing for allergic disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Skin testing is our preferred method of diagnosis. The sensitivity of testing with WBE preparations has been estimated to be between 76 and 94 percent, depending upon the concentration used [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. About 20 percent of patients with positive skin tests will have negative in vitro tests. Conversely, up to 20 percent of patients with negative skin tests can have positive in vitro tests, depending on the assays used [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/55,56\">",
"     55,56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Therefore, negative skin tests in patients with highly suggestive histories of systemic reactions should be followed by in vitro testing. If in vitro testing is negative in such patients, then we recommend repeat skin testing with another manufacturer's reagent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     In vitro tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are multiple in vitro tests available to detect V-IgE, including enzyme-linked immunosorbent assays (ELISA), radioallergosorbent tests (RAST), and Phadia CAP-solid phase system (ie, Phadia CAP-FEIA). All of these tests use whole body extract (WBE) as the allergen:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      WBE ELISA",
"     </li>",
"     <li>",
"      WBE RAST",
"     </li>",
"     <li>",
"      WBE Phadia ImmunoCAP solid phase assay (flow enzyme immunoassay)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Assays using venom are available only in research laboratories and may be more sensitive than those using whole body extracts [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/37\">",
"     37",
"    </a>",
"    ]. The sensitivities of the three commercially-available assays appear to be quantitatively similar to those of WBE intradermal skin tests [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/57\">",
"     57",
"    </a>",
"    ]. We use the WBE Phadia ImmunoCAP assay in our clinic.",
"   </p>",
"   <p>",
"    The absolute titer of a positive in vitro test does not predict the severity of the clinical reaction. Patients with severe anaphylaxis can have low positive titers.",
"   </p>",
"   <p>",
"    There are specific circumstances in which in vitro testing would be the initial modality of choice, such as in patients taking significant doses of beta-adrenergic blocking medications or with extensive skin disease. A discussion of situations in which in vitro testing would be preferred can be found elsewhere.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Management of local reactions",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Wheal and flare reactions and sterile pustules",
"      </strong>",
"      &mdash; No specific treatment is required for wheal and flare reactions and sterile pustules. Application of topical anti-itch preparations, such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?17/5/17491?source=see_link\">",
"       pramoxine",
"      </a>",
"      hydrochloride (1 percent) with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/49/32528?source=see_link\">",
"       hydrocortisone",
"      </a>",
"      acetate (1 percent) cream,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      a topical antihistamine (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/51/32560?source=see_link\">",
"       doxepin",
"      </a>",
"      cream 5 percent)",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      oral antihistamine treatment provide comfort until the itching stops. Itching can last for many hours. The lesions should be left intact as scratching can lead to infection [",
"      <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/52\">",
"       52",
"      </a>",
"      ]. Excoriated lesions should be kept clean with soap and water. Infected lesions require appropriate antimicrobial therapy.",
"     </li>",
"     <li>",
"      <strong>",
"       Large local reactions",
"      </strong>",
"      &mdash; Large local reactions at the site of stings often require treatment. Pruritus can be treated with the topical agents listed above or, if refractory, by oral antihistamines and high potency topical glucocorticoids. We prefer",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/34/36390?source=see_link\">",
"       cetirizine",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/56/30596?source=see_link\">",
"       fluocinonide",
"      </a>",
"      0.05 percent or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/16/10502?source=see_link\">",
"       clobetasol",
"      </a>",
"      0.05 percent ointment. Topical glucocorticoids are applied every four hours until the itching subsides.",
"      <br/>",
"      <br/>",
"      In individuals with predictable large local reactions, we have found that immediate application of high potency topical glucocorticoids and administration of a single dose of 20 mg of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      attenuates the response.",
"      <br/>",
"      <br/>",
"      Patients who experience large local reactions uniformly have venom-specific IgE; however, they are not believed to be at significantly higher risk for subsequent systemic reactions. Thus, testing for venom specific IgE and immunotherapy is not routinely offered.",
"     </li>",
"     <li>",
"      <strong>",
"       Extreme local reactions",
"      </strong>",
"      &mdash; Extreme local reactions may merit skin testing and venom immunotherapy for the prevention of recurrent extreme local reactions. This approach is similar to that used for large local reactions to winged Hymenoptera stings [",
"      <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/58\">",
"       58",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/34/16936?source=see_link&amp;anchor=H14#H14\">",
"       \"Hymenoptera venom immunotherapy: Efficacy, indications, and mechanism of action\", section on 'Patients with large local reactions'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Potential complications",
"      </strong>",
"      &mdash; In some patients with large or extreme local reactions, there may be enough induration, pain, and heat at the site to suggest cellulitis. However, fire ant venom alkaloids have both antibacterial and antifungal properties and cellulitis rarely occurs in nondiabetic patients. The presence of a sterile pustule is a clear indicator that these are late phase reactions to IFA. However, if the clinician is unsure, a course of oral antibiotics may be appropriate. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12825?source=see_link\">",
"       \"Cellulitis and erysipelas\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Management of allergic reactions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of an IFA-allergic patient involves acute management, education, and possible immunotherapy for prevention of recurrent systemic reactions. Patients should also obtain a medical identification bracelet or necklace stating that they have a life-threatening allergy to IFA.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Emergency treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute management of fire ant induced anaphylaxis is identical to the treatment of anaphylaxis from other causes, with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35824?source=see_link\">",
"     epinephrine",
"    </a>",
"    being the drug of choice. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35290?source=see_link&amp;anchor=H18#H18\">",
"     \"Anaphylaxis: Rapid recognition and treatment\", section on 'Immediate management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3006948\">",
"    <span class=\"h3\">",
"     Epinephrine autoinjectors",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients with IFA venom allergy should be equipped with an",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35824?source=see_link\">",
"     epinephrine",
"    </a>",
"    autoinjector and advised to have it immediately available at all times. Epinephrine must be accompanied by clear instructions for proper use of the device as well as instructions about which symptoms should prompt its use. Epinephrine should be injected intramuscularly in the thigh, preferably with the patient supine. It should be administered without delay for the following symptoms:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Difficulty",
"      <span class=\"nowrap\">",
"       breathing/wheezing",
"      </span>",
"     </li>",
"     <li>",
"      Throat",
"      <span class=\"nowrap\">",
"       tightness/hoarse",
"      </span>",
"      voice",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Lightheadedness/altered",
"      </span>",
"      mental status",
"     </li>",
"     <li>",
"      Widespread hives",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Information about prescribing",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35824?source=see_link\">",
"     epinephrine",
"    </a>",
"    autoinjectors, as well as patient information about the optimal use of these devices, is provided separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/17/23832?source=see_link\">",
"     \"Prescribing epinephrine for anaphylaxis self-treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?27/30/28134?source=see_link\">",
"     \"Patient information: Use of an epinephrine autoinjector (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Venom immunotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immunotherapy is recommended for the treatment of IFA allergy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H500112\">",
"    <span class=\"h4\">",
"     Efficacy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The efficacy in preventing recurrent systemic reactions cannot be defined because the natural history of IFA allergy has not been adequately studied. Specifically, it is not known with what frequency an IFA-allergic individual will exhibit systemic symptoms upon subsequent stings [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The best evidence for the efficacy of IFA immunotherapy is provided by unblinded, non-randomized studies.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study of 65 subjects with previous anaphylaxis who were treated with immunotherapy, 47 (72 percent) unexpectedly sustained IFA stings and only one had anaphylaxis [",
"      <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/60\">",
"       60",
"      </a>",
"      ]. In addition, 31 subjects underwent fire ant stings under direct observation and none had anaphylactic reactions while receiving maintenance immunotherapy. In contrast, there were 11 fire ant allergic subjects in the control group who declined immunotherapy, of whom six sustained unexpected field stings. All six had anaphylactic reactions.",
"     </li>",
"     <li>",
"      Two reports of successful rush fire ant immunotherapy protocol (an accelerated form of immunotherapy) have been published [",
"      <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/61,62\">",
"       61,62",
"      </a>",
"      ]. In a two-day program with 58 adult subjects, three (5.2 percent) experienced systemic reactions during the protocol, which were reported to be \"mild\" (",
"      <a class=\"graphic graphic_table graphicRef67225 \" href=\"UTD.htm?27/38/28268\">",
"       table 3",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/62\">",
"       62",
"      </a>",
"      ]. This approach is typically more costly because it must be performed under continuous observation, but it can be useful if protection is required quickly, such as in military personnel. Sting challenges with IFA were performed 20 days later on 56 of the subjects with more than 112 ant stings among the group. One mild systemic reaction occurred with a clinical efficacy of this rush protocol reported to be 98 percent.",
"     </li>",
"     <li>",
"      Another report described a one-day rush protocol that was successfully administered to three children under three years of age [",
"      <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/63\">",
"       63",
"      </a>",
"      ]. No systemic reactions occurred during the procedure.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H500145\">",
"    <span class=\"h4\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immunotherapy to prevent recurrent IFA-induced systemic reactions for:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Adults who have experienced a systemic reaction to IFA stings.",
"     </li>",
"     <li>",
"      Children who have had systemic reactions that extend beyond the skin.",
"     </li>",
"     <li>",
"      The value of immunotherapy in children with systemic reactions limited to the skin",
"      <strong>",
"      </strong>",
"      (ie, generalized urticaria, angioedema, pruritus, erythema, but without symptoms in other organ systems) in response to fire ant stings has not been well studied. With flying hymenoptera hypersensitivity (bees, wasps, yellow jackets, and hornets), a very low risk for future systemic reactions is observed in pediatric patients younger than 17 years who experience systemic cutaneous reactions. Such patients are not routinely treated with immunotherapy. However, it is not clear that children with these reactions in response to fire ant stings are similarly at low risk for anaphylaxis. Most allergists do not routinely recommend immunotherapy for such children in the absence of respiratory or vasomotor symptoms. This approach is supported by a retrospective analysis of fire ant stings in children under 16 [",
"      <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/64\">",
"       64",
"      </a>",
"      ]. Nevertheless, about one-third of responding clinicians in an endemic area did recommend immunotherapy because of the greater risk of re-stings compared to non-endemic areas [",
"      <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/5,65\">",
"       5,65",
"      </a>",
"      ]. In our clinic, we offer immunotherapy for children with respiratory or vascular features, but not for children with systemic cutaneous reactions, with the acknowledgment that there are inadequate data in these areas.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h4\">",
"     Protocols",
"    </span>",
"    &nbsp;&mdash;&nbsp;Whole body extracts (WBE) of imported fire ants contain adequate amounts of venom and are used in immunotherapy, in contrast to whole body preparations of flying hymenoptera. Whole body vaccine (WBV) is a term used for the solution used in immunotherapy that is prepared from WBE.",
"   </p>",
"   <p>",
"    Pure fire ant venom is unavailable commercially and has not been studied for immunotherapy. We recommend confirming the venom content of each lot of WBE prior to use, as discussed previously. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Skin testing'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Conventional immunotherapy protocols with fire ant whole body vaccines consist of weekly subcutaneous injections of gradually increasing doses of WBV. The stock is available as 1:10",
"    <span class=\"nowrap\">",
"     weight/volume",
"    </span>",
"    extract. We start with 0.05 mL of a 1:100,000",
"    <span class=\"nowrap\">",
"     weight/volume",
"    </span>",
"    solution, depending on the severity of the reaction and the degree of skin test positivity. We proceed stepwise to 0.5 mL before moving to the next 10-fold more concentrated dilution (",
"    <a class=\"graphic graphic_table graphicRef82716 \" href=\"UTD.htm?7/62/8174\">",
"     table 4",
"    </a>",
"    ). Our desired maintenance dose is 0.5 mL of a 1:100",
"    <span class=\"nowrap\">",
"     weight/volume",
"    </span>",
"    extract, given monthly. This dose contains the same amount of venom as approximately 19 fire ant stings [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/66\">",
"     66",
"    </a>",
"    ]. We continue maintenance injections for three to five years. The optimal maintenance dose has not been established. One large survey of 1091 prescriptions for fire ant immunotherapy submitted by over 300 practices serving personnel in the United States military found that the most commonly prescribed maintenance dose was 0.5 mL of a 1:200",
"    <span class=\"nowrap\">",
"     weight/volume",
"    </span>",
"    extract [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We do not mix WBV with other extracts in immunotherapy. The compatibility of WBV with other allergen extracts has not been extensively investigated, but one study demonstrated that WBV degraded the proteins in timothy grass extract [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/68\">",
"     68",
"    </a>",
"    ]. There was no apparent degradation of proteins in extracts of cat, ragweed, or dust mite.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H500160\">",
"    <span class=\"h4\">",
"     Safety",
"    </span>",
"    &nbsp;&mdash;&nbsp;The safety of conventional immunotherapy for fire ant allergy was reviewed in a retrospective series of 77 patients who had received 1887 injections. Systemic allergic reactions to the immunotherapy itself occurred in 9 percent of patients and were mild [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/35\">",
"     35",
"    </a>",
"    ]. Risk factors for a systemic reaction to immunotherapy included large local reactions or a history of systemic allergic reaction during diagnostic skin testing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h4\">",
"     Rush protocols",
"    </span>",
"    &nbsp;&mdash;&nbsp;A one-day rush protocol consisting of 10 injections has been described, which was successfully completed in 28 of 37 (76 percent) of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/69\">",
"     69",
"    </a>",
"    ]. Those who developed allergic symptoms during the protocol were transitioned to a conventional immunotherapy protocol. No premedications were administered prior to the injections. Of the nine patients who developed reactions, seven had generalized pruritus or urticaria and two had systemic reactions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3006863\">",
"    <span class=\"h4\">",
"     Duration of immunotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;We offer IFA immunotherapy for three to five years. However, if a patient has been receiving immunotherapy and is stung in the field without developing symptoms, we would allow the patient to stop after three years. There are no controlled trials evaluating the optimal length of treatment with fire ant WBE.",
"   </p>",
"   <p>",
"    We do not repeat skin testing in preparation of discontinuing treatment. If the patient is reluctant to stop immunotherapy after an appropriate interval, we offer a sting challenge under controlled circumstances in the hospital. Patients should continue to carry",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35824?source=see_link\">",
"     epinephrine",
"    </a>",
"    autoinjectors if they have histories of anaphylaxis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1954914\">",
"    <span class=\"h4\">",
"     Immunotherapy failure",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common reason for immunotherapy &ldquo;failure&rdquo; is patient noncompliance. Even patients who have experienced anaphylaxis need attention, encouragement, and follow-up to assure compliance [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/70\">",
"     70",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In our experience, the most frequent technical reason for recurrent systemic reactions to fire ants stings, despite having received immunotherapy with IFA WBE, is use of an extract containing little or no IFA venom. This is a problem unique to fire ant immunotherapy, as fire ants extracts are the only WBEs currently in use and the venom content of these preparations is variable. For this reason, we test each lot of IFA WBE by using it to skin test an individual with known reactivity to IFA, before the extract is used for skin testing and immunotherapy in other patients, as discussed previously. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Skin testing'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The possibility that the IFA WBE used for immunotherapy contains minimal fire ant venom can be investigated by skin testing the patient with the extract in question, at the concentration used for routine skin testing. If the patient has a negative result, than the problem is revealed. Under these circumstances, we recommend that IFA immunotherapy be reinitiated with an active extract. We prefer administering a new extract composed of two different lots of extracts known to induce positive skin test reactions in such a patient.",
"   </p>",
"   <p>",
"    If the above approach fails, increasing the volume of the maintenance extract using two separate injections up to 0.5 mL of the maintenance concentration in two separate sites may be of benefit.",
"   </p>",
"   <p>",
"    In patients with systemic reactions to IFA immunotherapy, in whom higher maintenance doses might pose a risk,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/46/38629?source=see_link\">",
"     omalizumab",
"    </a>",
"    has been reported to be helpful [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/71\">",
"     71",
"    </a>",
"    ]. These practices are based on clinical experience; there are no published data on the optimal management of such patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Massive attacks",
"    </span>",
"    &nbsp;&mdash;&nbsp;If any fire ants are found on a debilitated patient, clinical evaluation is needed, with possible transport (depending upon findings) to the nearest emergency department. We have made recommendations on how to proceed with patient care and facility management if this occurs [",
"    <a class=\"abstract\" href=\"UTD.htm?7/51/7994/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is no evidence that individuals who experience massive fire ant stings, in the absence of systemic allergic reactions or generalized late-phase dermal reactions, require parenteral glucocorticoid or antibiotic therapy. Treatment with large doses of glucocorticoids and intravenous fluids may complicate the management of those with preexisting cardiovascular disease.",
"   </p>",
"   <p>",
"    Treatment with oral nonsedating antihistamines and topical glucocorticoids appears to be adequate in most cases. We use the medications mentioned previously for either uncomplicated local or large local reactions depending on the cutaneous response.",
"   </p>",
"   <p>",
"    Measures to prevent indoor infestation by IFAs are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/36/7752?source=see_link\">",
"     \"Entomology and control of imported fire ants\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?24/42/25250?source=see_link\">",
"       \"Patient information: Insect allergy (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?18/44/19138?source=see_link\">",
"       \"Patient information: Fire ants (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Imported fire ants (IFAs) are aggressive, venomous ants that sting with little provocation and are difficult to avoid in endemic areas (throughout the southern United States). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Territory'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Fire ant stings produce an immediate, intense burning (the \"fire\" inspiring the name) and itching at the sting site. Stings occur most frequently during summer, most commonly in children, and typically on the lower extremities. (See",
"      <a class=\"local\" href=\"#H499132\">",
"       'Clinical reactions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most people develop only local reactions, which may take several forms, including wheal and flare reactions, sterile pustules, and large local reactions. Local reactions are contiguous with the sting site. (See",
"      <a class=\"local\" href=\"#H499191\">",
"       'Local reactions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment of local reactions is symptomatic and not always necessary. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Management of local reactions'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For patients with uncomfortable wheal and flare reactions, we suggest the application of low-potency topical glucocorticoids",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      oral antihistamines (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Large local reactions often require treatment with topical agents and oral antihistamines. High-potency topical glucocorticoids may be required. For severe swelling, we suggest administration of oral",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      (60 mg given as a single dose) and elevation of the affected extremity (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Some individuals develop systemic allergic reactions, which can range from cutaneous symptoms (generalized urticaria, angioedema, pruritus, erythema) to life-threatening anaphylaxis. Anaphylaxis may occur within minutes after a sting, or on rare occasions, can develop hours after. The pathognomonic sterile pustules can later identify the fire ant as the culprit. (See",
"      <a class=\"local\" href=\"#H499216\">",
"       'Systemic allergic reactions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with systemic allergic reactions must be treated emergently for anaphylaxis and equipped with an",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/63/35824?source=see_link\">",
"       epinephrine",
"      </a>",
"      autoinjector for self-treatment of possible future reactions. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35290?source=see_link\">",
"       \"Anaphylaxis: Rapid recognition and treatment\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with allergic reactions should be referred to an allergy expert. The diagnosis of IFA venom allergy requires the demonstration of venom-specific IgE (V-IgE) by skin testing or in vitro tests. Skin testing is the preferred method, but in vitro testing is available if the skin is compromised or if there is a medical contraindication to skin testing. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients with confirmed IFA venom allergy, we recommend three to five years of venom immunotherapy with commercially-available whole body IFA vaccines (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Various protocols have been established. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Massive attacks, in which individuals sustain hundreds or thousands of stings, have been reported. Multiple stings can result in a variety of toxic reactions, such as serum sickness, nephrotic syndrome, seizures, mononeuritis, and worsening of preexisting cardiopulmonary disease. Treatment should be individualized to the patient's symptoms, and we suggest",
"      <strong>",
"       against",
"      </strong>",
"      empirically administering large doses of glucocorticoids and intravenous fluids, particularly in debilitated patients and those with preexisting cardiovascular disease (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). For most patients with multiple stings, the interventions suggested for local reactions are sufficient. (See",
"      <a class=\"local\" href=\"#H499243\">",
"       'Toxic reactions'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/1\">",
"      Lofgren CS, Banks WA, Glancey BM. Biology and control of imported fire ants. Annu Rev Entomol 1975; 20:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/2\">",
"      Kemp SF, deShazo RD, Moffitt JE, et al. Expanding habitat of the imported fire ant (Solenopsis invicta): a public health concern. J Allergy Clin Immunol 2000; 105:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/3\">",
"      Sanchez-Pena SR, Patrock RJW, Gilbert LA. The red imported fire ant is now in Mexico: documentation of its wide distribution along the Texas-Mexico border. Entomol News 2005; 116:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/4\">",
"      McCubbin KI, Weiner JM. Fire ants in Australia: a new medical and ecological hazard. Med J Aust 2002; 176:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/5\">",
"      Tracy JM, Demain JG, Quinn JM, et al. The natural history of exposure to the imported fire ant (Solenopsis invicta). J Allergy Clin Immunol 1995; 95:824.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/6\">",
"      Haight KL, Tschinkel WR. Patterns of venom synthesis and use in the fire ant, Solenopsis invicta. Toxicon 2003; 42:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/7\">",
"      Hannan CJ Jr, Stafford CT, Rhoades RB, et al. Seasonal variation in antigens of the imported fire ant Solenopsis invicta. J Allergy Clin Immunol 1986; 78:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/8\">",
"      Goddard J. Personal protection measures against fire ant attacks. Ann Allergy Asthma Immunol 2005; 95:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/9\">",
"      Baer H, Liu TY, Anderson MC, et al. Protein components of fire ant venom (Solenopsis invicta). Toxicon 1979; 17:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/10\">",
"      Hoffman DR. Fire ant venom allergy. Allergy 1995; 50:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/11\">",
"      Hoffman DR. Allergens in Hymenoptera venom XXIV: the amino acid sequences of imported fire ant venom allergens Sol i II, Sol i III, and Sol i IV. J Allergy Clin Immunol 1993; 91:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/12\">",
"      Hoffman DR. Allergens in hymenoptera venom. XXVI: The complete amino acid sequences of two vespid venom phospholipases. Int Arch Allergy Immunol 1994; 104:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/13\">",
"      Hoffman DR, Dove DE, Moffitt JE, Stafford CT. Allergens in Hymenoptera venom. XXI. Cross-reactivity and multiple reactivity between fire ant venom and bee and wasp venoms. J Allergy Clin Immunol 1988; 82:828.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/14\">",
"      Schmidt M, Walker RB, Hoffman DR, McConnell TJ. Nucleotide sequence of cDNA encoding the fire ant venom protein Sol i II. FEBS Lett 1993; 319:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/15\">",
"      Blum MS, Roberts JE, Novak AF. Chemical and biological characterization of venom of the ant Solenopsis xyloni McCook. Psyche, Camb 1961; 68:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/16\">",
"      Brand JM, Blum MS, Fales HM, MacConnell JG. Fire ant venoms: comparative analyses of alkaloidal components. Toxicon 1972; 10:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/17\">",
"      Deslippe RJ, Guo YJ. Venom alkaloids of fire ants in relation to worker size and age. Toxicon 2000; 38:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/18\">",
"      MacConnell JG, Blum MS, Fales HM. The chemistry of fire ant venom. Tetrahedron 1971; 26:1129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/19\">",
"      Leclerq S, Braekman JC, Daloze D, et al. Biosynthesis of the solenopsins, venom alkaloids of the fire ant. Naturwissenschaften 1996; 83:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/20\">",
"      ADROUNY GA, DERBES VJ, JUNG RC. Isolation of a hemolytic component of fire ant venom. Science 1959; 130:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/21\">",
"      Koch RB, Desaiah D, Foster D, Ahmed K. Effect of piperidines and fire ant venom on ATPase activities from brain homogenate fractions and characterization of Na+-K+ ATPase inhibition. Biochem Pharmacol 1977; 26:983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/22\">",
"      Koch RB, Desaiah D. Sensitivity of ATPase activities to fire ant venom and abdomen preparations. Life Sci 1975; 17:1315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/23\">",
"      Cheng EY, Cutkomp LK, Koch RB. Effect of an imported fire ant venom component on respiration and oxidative phosphorylation of mitochondria. Biochem Pharmacol 1977; 26:1179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/24\">",
"      Jouvenaz DP, Blum MS, MacCONNELL JG. Antibacterial activity of venom alkaloids from the imported fire ant, Solenopsis invicta Buren. Antimicrob Agents Chemother 1972; 2:291.",
"     </a>",
"    </li>",
"    <li>",
"     Rhoades RB. Medical aspects of the imported fire ant, The University Presses of Florida, Gainesville, FL 1977.",
"    </li>",
"    <li>",
"     Vander Meer RK. Behavioral and biochemical variation in the fire ant, Solenopsis invicta. In: Interindividual behavioral variability in social insects, Jeanne RL (Ed), Westview Press, Boulder 1988.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/27\">",
"      Javors MA, Zhou W, Maas JW Jr, et al. Effects of fire ant venom alkaloids on platelet and neutrophil function. Life Sci 1993; 53:1105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/28\">",
"      Read GW, Lind NK, Oda CS. Histamine release by fire ant (Solenopsis) venom. Toxicon 1978; 16:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/29\">",
"      Lind NK. Mechanism of action of fire ant (Solenopsis) venoms. I. Lytic release of histamine from mast cells. Toxicon 1982; 20:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/30\">",
"      Yeh JZ, Narahashi T, Almon RR. Characterization of neuromuscular blocking action of piperidine derivatives. J Pharmacol Exp Ther 1975; 194:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/31\">",
"      Yi GB, McClendon D, Desaiah D, et al. Fire ant venom alkaloid, isosolenopsin A, a potent and selective inhibitor of neuronal nitric oxide synthase. Int J Toxicol 2003; 22:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/32\">",
"      Howell G, Butler J, Deshazo RD, et al. Cardiodepressant and neurologic actions of Solenopsis invicta (imported fire ant) venom alkaloids. Ann Allergy Asthma Immunol 2005; 94:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/33\">",
"      Rhoades RB, Schafer WL, Newman M, et al. Hypersensitivity to the imported fire ant in Florida. Report of 104 cases. J Fla Med Assoc 1977; 64:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/34\">",
"      deShazo RD, Griffing C, Kwan TH, et al. Dermal hypersensitivity reactions to imported fire ants. J Allergy Clin Immunol 1984; 74:841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/35\">",
"      La Shell MS, Calabria CW, Quinn JM. Imported fire ant field reaction and immunotherapy safety characteristics: the IFACS study. J Allergy Clin Immunol 2010; 125:1294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/36\">",
"      Adams CT, Lofgren CS. Red imported fire ants (Hymenoptera: Formicidae): frequency of sting attacks on residents of Sumter County, Georgia. J Med Entomol 1981; 18:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/37\">",
"      Stafford CT. Hypersensitivity to fire ant venom. Ann Allergy Asthma Immunol 1996; 77:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/38\">",
"      Caldwell ST, Schuman SH, Simpson WM Jr. Fire ants: a continuing community health threat in South Carolina. J S C Med Assoc 1999; 95:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/39\">",
"      Rhoades RB, Stafford CT, James FK Jr. Survey of fatal anaphylactic reactions to imported fire ant stings. Report of the Fire Ant Subcommittee of the American Academy of Allergy and Immunology. J Allergy Clin Immunol 1989; 84:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/40\">",
"      Prahlow JA, Barnard JJ. Fatal anaphylaxis due to fire ant stings. Am J Forensic Med Pathol 1998; 19:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/41\">",
"      Caplan EL, Ford JL, Young PF, Ownby DR. Fire ants represent an important risk for anaphylaxis among residents of an endemic region. J Allergy Clin Immunol 2003; 111:1274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/42\">",
"      Nugent JS, More DR, Hagan LL, et al. Cross-reactivity between allergens in the venom of the common striped scorpion and the imported fire ant. J Allergy Clin Immunol 2004; 114:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/43\">",
"      deShazo RD, Williams DF, Moak ES. Fire ant attacks on residents in health care facilities: a report of two cases. Ann Intern Med 1999; 131:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/44\">",
"      Swanson GP, Leveque JA. Nephrotic syndrome associated with ant bite. Tex Med 1990; 86:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/45\">",
"      Fox RW, Lockey RF, Bukantz SC. Neurologic sequelae following the imported fire ant sting. J Allergy Clin Immunol 1982; 70:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/46\">",
"      Rupp MR, deShazo RD. Indoor fire ant sting attacks: a risk for frail elders. Am J Med Sci 2006; 331:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/47\">",
"      Flickinger EL. Observation of predation by red imported fire ants on live-trapped wild cotton rats. Texas J Sci 1989; 41:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/48\">",
"      Diaz JD, Lockey RF, Stablein JJ, Mines HK. Multiple stings by imported fire ants (Solenopsis invicta), without systemic effects. South Med J 1989; 82:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/49\">",
"      deShazo RD, Kemp SF, deShazo MD, Goddard J. Fire ant attacks on patients in nursing homes: an increasing problem. Am J Med 2004; 116:843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/50\">",
"      More DR, Kohlmeier RE, Hoffman DR. Fatal anaphylaxis to indoor native fire ant stings in an infant. Am J Forensic Med Pathol 2008; 29:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/51\">",
"      Triplett RF. Sensitivity to the imported fire ant: successful treatment with immunotherapy. South Med J 1973; 66:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/52\">",
"      deShazo RD, Butcher BT, Banks WA. Reactions to the stings of the imported fire ant. N Engl J Med 1990; 323:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/53\">",
"      Stafford CT, Wise SL, Robinson DA, et al. Safety and efficacy of fire ant venom in the diagnosis of fire ant allergy. J Allergy Clin Immunol 1992; 90:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/54\">",
"      Bahna SL, Strimas JH, Reed MA, Butcher BT. Imported fire ant allergy in young children: skin reactivity and serum IgE antibodies to venom and whole body extract. J Allergy Clin Immunol 1988; 82:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/55\">",
"      Golden DB, Kagey-Sobotka A, Norman PS, et al. Insect sting allergy with negative venom skin test responses. J Allergy Clin Immunol 2001; 107:897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/56\">",
"      Reisman RE. Insect sting allergy: the dilemma of the negative skin test reactor. J Allergy Clin Immunol 2001; 107:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/57\">",
"      Ford JL, Dolen WK, Feger TA, et al. Evaluation of an in vitro assay for fire ant venom-specific IgE. J Allergy Clin Immunol 1997; 100:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/58\">",
"      Golden DB, Moffitt J, Nicklas RA, et al. Stinging insect hypersensitivity: a practice parameter update 2011. J Allergy Clin Immunol 2011; 127:852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/59\">",
"      Brown SG, Heddle RJ, Wiese MD, Blackman KE. Efficacy of ant venom immunotherapy and whole body extracts. J Allergy Clin Immunol 2005; 116:464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/60\">",
"      Freeman TM, Hylander R, Ortiz A, Martin ME. Imported fire ant immunotherapy: effectiveness of whole body extracts. J Allergy Clin Immunol 1992; 90:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/61\">",
"      Duplantier JE, Freeman TM, Bahna SL, et al. Successful rush immunotherapy for anaphylaxis to imported fire ants. J Allergy Clin Immunol 1998; 101:855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/62\">",
"      Tankersley MS, Walker RL, Butler WK, et al. Safety and efficacy of an imported fire ant rush immunotherapy protocol with and without prophylactic treatment. J Allergy Clin Immunol 2002; 109:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/63\">",
"      Judd CA, Parker AL, Meier EA, Tankersley MS. Successful administration of a 1-day imported fire ant rush immunotherapy protocol. Ann Allergy Asthma Immunol 2008; 101:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/64\">",
"      Nguyen SA, Napoli DC. Natural history of large local and generalized cutaneous reactions to imported fire ant stings in children. Ann Allergy Asthma Immunol 2005; 94:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/65\">",
"      Moffitt JE, Barker JR, Stafford CT. Management of imported fire ant allergy: results of a survey. Ann Allergy Asthma Immunol 1997; 79:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/66\">",
"      Hoffman DR, Jacobson RS, Schmidt M, Smith AM. Allergens in Hymenoptera venoms. XXIII. Venom content of imported fire ant whole body extracts. Ann Allergy 1991; 66:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/67\">",
"      Haymore BR, McCoy RL, Nelson MR. Imported fire ant immunotherapy prescribing patterns in a large health care system during a 17-year period. Ann Allergy Asthma Immunol 2009; 102:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/68\">",
"      Rans TS, Hrabak TM, Whisman BA, et al. Compatibility of imported fire ant whole body extract with cat, ragweed, Dermatophagoides pteronyssinus, and timothy grass allergens. Ann Allergy Asthma Immunol 2009; 102:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/69\">",
"      Dietrich JJ, Moore LM, Nguyen S, et al. Imported fire ant hypersensitivity: a 1-day rush immunotherapy schedule without premedication. Ann Allergy Asthma Immunol 2009; 103:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/70\">",
"      Stokes SC, Quinn JM, Sacha JJ, White KM. Adherence to imported fire ant subcutaneous immunotherapy. Ann Allergy Asthma Immunol 2013; 110:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/51/7994/abstract/71\">",
"      Tartibi HM, Majmundar AR, Khan DA. Successful use of omalizumab for prevention of fire ant anaphylaxis. J Allergy Clin Immunol 2010; 126:664.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4092 Version 19.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-118.195.65.247-9CA6F9C4F1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_51_7994=[""].join("\n");
var outline_f7_51_7994=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H32\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TERRITORY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Red imported fire ants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Black imported fire ants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H496031\">",
"      APPEARANCE AND BEHAVIORS OF IFA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H500021\">",
"      Fire ant avoidance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H498141\">",
"      VENOM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H498148\">",
"      Protein allergens",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H498170\">",
"      Venom alkaloids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7806077\">",
"      Cross-reactivity with other Hymenoptera species",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H499132\">",
"      CLINICAL REACTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H499191\">",
"      Local reactions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H499216\">",
"      Systemic allergic reactions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H499243\">",
"      Toxic reactions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H499271\">",
"      - Massive attacks",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10543224\">",
"      INDICATIONS FOR REFERRAL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Local reactions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Systemic allergic reactions: testing for IFA venom allergy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10543325\">",
"      - Laboratory studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Skin testing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - In vitro tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Management of local reactions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Management of allergic reactions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Emergency treatment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3006948\">",
"      - Epinephrine autoinjectors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Venom immunotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H500112\">",
"      Efficacy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H500145\">",
"      Indications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Protocols",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H500160\">",
"      Safety",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Rush protocols",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H3006863\">",
"      Duration of immunotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H1954914\">",
"      Immunotherapy failure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Massive attacks",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/4092\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/4092|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?7/44/7873\" title=\"figure 1\">",
"      Mature fire ant colonies size",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/4092|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/2/43042\" title=\"picture 1\">",
"      Local reactions to IFA stings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?18/52/19264\" title=\"picture 2\">",
"      Sterile pustules with IFA sting",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/4092|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/48/30475\" title=\"table 1\">",
"      Antigenic features of IFA venom",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/49/20251\" title=\"table 2\">",
"      Manifestations of IgE rxns",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?27/38/28268\" title=\"table 3\">",
"      Rush fire ant immunotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?7/62/8174\" title=\"table 4\">",
"      Dosing schedules immunotherapy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35290?source=related_link\">",
"      Anaphylaxis: Rapid recognition and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12825?source=related_link\">",
"      Cellulitis and erysipelas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/36/7752?source=related_link\">",
"      Entomology and control of imported fire ants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/13/18650?source=related_link\">",
"      Evaluation and diagnosis of mastocytosis (cutaneous and systemic)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/34/16936?source=related_link\">",
"      Hymenoptera venom immunotherapy: Efficacy, indications, and mechanism of action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32633?source=related_link\">",
"      Overview of skin testing for allergic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?18/44/19138?source=related_link\">",
"      Patient information: Fire ants (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?24/42/25250?source=related_link\">",
"      Patient information: Insect allergy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/30/28134?source=related_link\">",
"      Patient information: Use of an epinephrine autoinjector (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/17/23832?source=related_link\">",
"      Prescribing epinephrine for anaphylaxis self-treatment",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_51_7995="Caveats";
var content_f7_51_7995=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F72133&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F72133&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Caveats re intervention",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td>",
"       &bull; Do not succumb to your instinct to avoid the issue (Conspiracy of Silence).",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; Intervention is worth it. Coercion works!",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; The initial anger is later replaced with gratitude.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; Job is the last to go. When the symptoms of addiction spill into the workplace, the addiction is advanced and the symptoms identified are only the tip of the iceberg.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; Their life will be better. Treatment has a high success rate for physicians.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; Confidentiality can usually be maintained.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; The physician's career will be maintained. Outcome studies demonstrate that most physicians return to practice.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; Do not do this alone. Help is available.",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_51_7995=[""].join("\n");
var outline_f7_51_7995=null;
var title_f7_51_7996="CLIP score for HCC";
var content_f7_51_7996=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F69726&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F69726&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    CLIP (Cancer of the Liver Italian Program) scoring system for hepatocellular cancer",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Variable",
"       </td>",
"       <td class=\"subtitle1\">",
"        Score",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Child-Pugh stage",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        A",
"       </td>",
"       <td>",
"        0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        B",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        C",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Tumor morphology",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Uninodular and extension &le;50 percent",
"       </td>",
"       <td>",
"        0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Multinodular and extension &le;50 percent",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Massive or extension &gt;50 percent",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Alpha-fetoprotein",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        &lt;400",
"       </td>",
"       <td>",
"        0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        &ge;400",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Portal vein thrombosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        No",
"       </td>",
"       <td>",
"        0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Yes",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    The Cancer of the Liver Italian Program (CLIP) score has been used to predict survival in patients with hepatocellular carcinoma. The total score is derived by adding each of the subscores. In one study, median survival was 36, 22, 9, 7, and 3 months for patients in CLIP categories 0, 1, 2, 3, and 4 to 6, respectively.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Prospective validation of the CLIP score: A new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 2000; 31:840. Copyright &copy; 2000 Elsevier Science.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_51_7996=[""].join("\n");
var outline_f7_51_7996=null;
var title_f7_51_7997="LR after neoadj tx and BCT";
var content_f7_51_7997=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F62394&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F62394&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Locoregional recurrence rate for breast-conserving surgery after NACT",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Study",
"      </td>",
"      <td class=\"subtitle1\">",
"       n",
"      </td>",
"      <td class=\"subtitle1\">",
"       LRR (percent)",
"      </td>",
"      <td class=\"subtitle1\">",
"       Median follow-up (mo)",
"      </td>",
"      <td class=\"subtitle1\">",
"       Year of publication",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Asoglu, et al",
"       <sup>",
"        [1]",
"       </sup>",
"      </td>",
"      <td>",
"       28",
"      </td>",
"      <td>",
"       14",
"      </td>",
"      <td>",
"       60",
"      </td>",
"      <td>",
"       2005",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Chen, et al",
"       <sup>",
"        [2]",
"       </sup>",
"      </td>",
"      <td>",
"       340",
"      </td>",
"      <td>",
"       5",
"      </td>",
"      <td>",
"       60",
"      </td>",
"      <td>",
"       2004",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Clark, et al",
"       <sup>",
"        [3]",
"       </sup>",
"      </td>",
"      <td>",
"       34",
"      </td>",
"      <td>",
"       6.6",
"      </td>",
"      <td>",
"       30",
"      </td>",
"      <td>",
"       1998",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Hunt, et al",
"       <sup>",
"        [4]",
"       </sup>",
"      </td>",
"      <td>",
"       93",
"      </td>",
"      <td>",
"       9.7",
"      </td>",
"      <td>",
"       55",
"      </td>",
"      <td>",
"       1998",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Mauriac, et al",
"       <sup>",
"        [5]",
"       </sup>",
"      </td>",
"      <td>",
"       272",
"      </td>",
"      <td>",
"       22.5",
"      </td>",
"      <td>",
"       124",
"      </td>",
"      <td>",
"       1999",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       McIntoch, et al",
"       <sup>",
"        [6]",
"       </sup>",
"      </td>",
"      <td>",
"       173&bull;",
"      </td>",
"      <td>",
"       2",
"      </td>",
"      <td>",
"       62",
"      </td>",
"      <td>",
"       2003",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       NSABP B18",
"       <sup>",
"        [7]",
"       </sup>",
"      </td>",
"      <td>",
"       1531",
"      </td>",
"      <td>",
"       10.7",
"      </td>",
"      <td>",
"       114",
"      </td>",
"      <td>",
"       2001",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Shen, et al",
"       <sup>",
"        [8]",
"       </sup>",
"      </td>",
"      <td>",
"       33",
"      </td>",
"      <td>",
"       6",
"      </td>",
"      <td>",
"       60",
"      </td>",
"      <td>",
"       2004",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     BCS: breast-conserving surgery; LRR: locoregional recurrence rate; NSABP: National Surgical Adjuvant Breast and Bowel Project.",
"     <br>",
"      &bull; Data available for 166.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     1. Asoglu, O, Muslumanoglu, M, Igci, A, et al. Breast conserving surgery after primary chemotherapy in locally advanced breast cancer. Acta Chir Belg 2005; 105:62.",
"     <br>",
"      2. Chen, AM, Meric-Bernstam, F, Hunt, KK, et al. Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience. J Clin Oncol 2004; 22:2303.",
"      <br>",
"       3. Clark, J, Rosenman, J, Cance, W, et al. Extending the indications for breast-conserving treatment to patients with locally advanced breast cancer. Int J Radiat Oncol Biol Phys 1998; 42:345.",
"       <br>",
"        4. Hunt, KK, Singletary, SE, Smith, TL. Conservation surgery and radiation: the M.D. Anderson experience. In: The Breast, 2nd ed, Bland, KI, Copeland, EM III (Eds), Saunders, Philadelphia 1998. p.1179.",
"        <br>",
"         5. Mauriac, L, MacGrogan, G, Avril, A, et al. Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonie Bordeaux Groupe Sein (IBBGS). Ann Oncol 1999; 10:47.",
"         <br>",
"          6. McIntosh, SA, Ogston, KN, Payne, S, et al. Local recurrence in patients with large and locally advanced breast cancer treated with primary chemotherapy. Am J Surg 2003; 185:525.",
"          <br>",
"           7. Wolmark, N, Wang, J, Mamounas, E, et al. Preoperative chemotherapy in patients with operable breast cancer: Nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr 2001; 30:96.",
"           <br>",
"            8. Shen, J, Valero, V, Buchholz, TA, et al. Effective local control and longterm survival in patients with T4 locally advanced breast cancer treated with breast conservation therapy. Ann Surg Oncol 2004; 11:854.",
"            <br>",
"             Data from: Alm El-Din, M, Taghian, A. Breast conserving therapy for patients with locally advanced breast cancer. Semin Radiat Oncol 2009; 19:229.",
"            </br>",
"           </br>",
"          </br>",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_51_7997=[""].join("\n");
var outline_f7_51_7997=null;
var title_f7_51_7998="Insulin relatives at risk";
var content_f7_51_7998=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F62801&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F62801&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 473px\">",
"   <div class=\"ttl\">",
"    Kalan-Meier curves: insulin therapy does not prevent type 1 diabetes in high risk family members",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 453px; height: 317px; background-image: url(data:image/gif;base64,R0lGODlhxQE9AeYAAP///4CAgAAAAH9/f4CZzP+AgMDAwEBAQD8/P9DQ0P/AwBAQEKCgoCAgIHBwcDAwMLCwsFBQUL+/v+Dg4JCQkPDw8P+goGBgYH+ZzA8PD5+fn6Cz2fDz+cDN5v9/f29vb0BmswAzmS8vLx8fH8/PzxBAn6+vr09PT2CAvzBZrI+Pj7DA39/f3+/v7yBNpv+wsF9fX/8AAP9AQHCNxv/w8P8gIP8QEFBzudDZ7P9gYP8wMODm85Cm0//g4P/Q0P9wcP+/v/+QkP9QUIBZjL/M5Q8vj896jWAwcD9Wou+jqb8MJnAsZb9shr+Mpu8DCZ9TeV8fX++zuc+pvJ8TOSA8lS8pfKBzmQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAADFAT0BAAf/gACCg4SFhoeIiYqLjI2Oj5CRkpOUlZaXmJmam5ydnp+goaKjpKWmp6ipqqusra6vsLGys7S1tre4ubq7vL2+v8DBwsPExcbHyMnKy8zNzs/Q0dLT1NXW19jZ2tvc3d7f4OHi4+Tl5ufo6err7O3u7/Dx8vP09fb3+PnNFQYGgwwHEgA44CBSggMMCgEUqK+hw1UOBAiAICiAAH8CDkQyICBAIQMBJjSy6O+hyZOSGki8UPEigIyFIEQ4cMHAhAD+bvYT4ODCAYogQwKY4PMCQwNFIRwQcCFhAp8REqKcShUABAEUFgioAIDkS43/BEQIMJajR7McGwR4ICABA5U2/xc8CLBgAQCOcw9EUPnAwQQBcy9EqErY5AUBRAUk9ApzEAXAARKavdtx8lWPJB9fCLDUQATEgm66TCCggQMKXAurxldB4gG+XV02HsRZooPJaDtSxnzR4uYAIZcS8mr1gNYHq5PX0wxcZQLGYAVRuM1ALOkFtXEyNcBWIEnSDyAYcJBAc1CLOJGKr6u8fTy2qSM6gE4IgkqxXCM2OKxd6wKpXkHAFmAiBaDSAhBMoFIEEwz4AEPuRSjhIPwsBeGEGGYICUc8aejhhyCGKOKIJJZo4okopqjiiiy26OKLMMYo44w01mjjjTjmqOOOPPbo449ABinkkEQWaeSRSCap5P+STDbp5JNIGnDhIBNQEABFUGbJynOzUVkXWwVF0gEBK3TAgZZoRrJUl4JERAEAWqVGyHnAAVdSE0sgkUIIIaQAwgxkmpnmoIZwFN0gnQ3k0kd11nmARwAooIMNOfjAQQcrEDADCHv2+WegZxIKpaGGJJooI8AR4kMONuiggCGXZrppp36isIKoS5JayGcUdTcSpITQYMGrjcRKQAk3hIprkeUBZgBXMFUXwVUNOJKqIgoUYAENjHBwQwm3PkRno+SWa+656Kar7rrstuvuu/CW1M6aEmEElgPHTZnItYlkKwOlxCqyArLK5hMAAgMkrPDCDDfs8MMQRyzxxBRXbPH/xRQjAGx7/C7SQwE11FBAD4p4C25DAQwQ4gAbK9dxIwqwKkPAhwycrMEqg8iyhC87IiyxCvzwAqzfboBPyiu3nFzPkmRrww/cFrKCCy4YXQ/So7AgwdYSxPIBArnsHCHTk9Aggw4+HLIB1VbLg7UoA0gkESJxdx2KAGADoEHOt4jtHtmUBBFDEIisXbXbfIsiAd6C7G3CCSeQwAICAsCgAQAtDIDACSYAIMEAJGgggQo5D6AC5ppzDgALA5jwtcoaCDDCACzsLQgJMCDwQQuet55754Vo/sEAl+/NggostPA1DCQIQrzzlxOvAsKH+M2x0pf4oIMMURtieNvtvK04/+MAUD6CCLKTMIIAInwAgAgZDIA+CXFnIMAAMAhAAgmVvx///IvDm/008AEBZAABJKDc6jIgggEwEAD1o5wAWECIAp4gbmCjnP0kAD/5ZYCC5GOcAT9wAgGcLnjYUw3gKkGDH9hgaIWjGqjWIT4AEAEDOMyhDnfIwx0SgRCLy5sC3ycACAqga/xDWP4SJgDgLe4DKjhiEvF3v8WpzAT3e4kQixjFzhWQfkcEQAHtJgjZlTGDAuAd/9yHxdOFEGyMawH5CGE9l6UQEz8owCI2sCkQ8MkFIEABAXjQARyMo4Y37KEiF4mBHw4iiIIYogLr5jm8KexzYRTE+UQwgkoiLP9hW8uiFbUYySJSsm6nzOQZVznEUY7yjaSMJR3vSJgVWkIBNGsEDjrAAwKgAAQu4BMIQECADnSjhp84Hvu6JklTVhEAGciA6FSwN1UWMIvQlOboRCfKLMpOApMrIv9OIIERZMCIXaPkINBngtihcRAZGIEEStg8+30gf3AUgQTyd8JZ8oyWsYjVL4+ZOFDETW7lK2JCV7e+EwCABCWUnQnUuTqJUPChER2BCVyZxYMmUKEaWJ8ImpdKMj50fZR75+3QN4LL6S2aBYRjNAXgPkPUcWkAvcQLYIgJDoRgB9xAZjoksNG41VQSc6xeTqdiS53aIG2ZQAEPglpQdcTOgDD/4N0kkmrTpaKkqZcogA66Z4mpUTVp/ySFEISgiRIYUhtCndBNVwPWS9BAB3rExAxmsI24SmiuJxkXZ7yavacV4LC5fAQOStDXqmIIsCYR7KNM8YLDIlYQ2RpWYhHhgnBhw68RgmwtCfsJf8mgBjGIQQ1kIIMCAG1bguABCuDqWLmS9iF1PQUuLeBazAohBjKwwA5CULBqgNY9oq1Kbl9BA8FZ4E/GvMZx25NcqiwXFhaIARNQsKcUSDW60ZiucqrL1NtiNwYWEAQvudun7zpDvJlg3fME8TVUaACBuyDvV8173vQWYr3dRcEGiksM+F4idudjH++GKIpW0i6//NXH/3VlYQH/JoKXfrTVMQxcCRbIjndRhEFCTYCArGLua9TTGwIQcDrWEVUDE6Xg3lowzxWfrpxV/BwFlVfi5rHOdSmmo+6eZzzkAWB6qtNbzmy3NwmUWKtKnQYDGFCBCLCEFhOuRbYsy2XE7oAHLijBDN4qDA5TIoo1leM5KQcDCwLAnAP4QCcLSEITLs5+CIjd6eIJQRhoTgAa0ACeq9m1DsJPaxJBwAArKIALMk6DR6RzCTvXzIS2udGJ0G8xGkCBw2AFyxGexZa7bNmA4WAGJXABD4AKjBoCwQOwjrWsgSCIV8v61rSmIzZfUsQhoi+bfqZgPJmIgCcKogUM5J/KWv+gghOgT2VDrNsaAdDGUWIxcWYkJeW0+kA5OrTSvlZolKVxkQcQ5FCwyHIwFABbAKwABSEAAXh54epb47rW9p51IbDo0Ieyb6ELhej6Pig7hXGTb/nLHwXhp4IoQluhdePoACROCFgy2OIKVWCl6RZqX2CnI5wBNTUU8K8cEIsDBADBL8xMiWebgJ0JHR2m8+xk/ZVw4k3eNRZDKM8CPtwEYOxaPOepP4qvs4nuBDgAJh2305XwBB+wX8yj2O9xRyMi5b6yLNQtjI+FbGQcKAGr6V3bTrQABvYTAfAgjQDeZfRyZ7df/EY5iPW59KqUu6L9SBdGErD0cka/HUofLe7/FpQwAzVVX6N/bT68Qbmr06gABSBQgQDoyxVcJ0bMWnUEAviC5dogKiaPGgkGK0LTxKiAAwIyLZFro7lKcMHnyz6Oq2bAxJMwfaY73ovPXEQwrt+GBagw71yAniqoHwZWDgASdEuiAgyIjJyoZCWpoIr3x/BlL44/leQLYyLM18sl2LIU5BAiAV9iEyIyj4wdlCAKpObyZlXBfZR4PxgXqItKrD+JqwyGV8PRIXNzfd8AAlYQf6UWC/V3EvcHDFUmAAsQJpWAHrGxMegnForxK9+wNjDTbvRHe8iFfbuQACIBACRoCRRIgVTyAA2gFVo3CJIlgsfgAsV3CJJCKVCF/woHgzE82IM++INAGIQQozHTMFld4XyQ8BgF4SaE8BnPAheMQi5G6A0boHKNsCqtYmGlIFjw0oVe+IVgGIZiSC7y4gwHsQANcADGgYSP8BcNYAAqIRIwcRgXAAFaUYKKwH7JEHY1mAjCEjJauCy/wCFygyCX8BalIRUw8YCAgSWLoIfJQAA3IAkWEDI8JYi/4AD8F3zeEHZjBwkWMDQvEIiYqAsQEBKWx4neMAOzVQkvAIiluAtY5xkvmG4y2H4/dQmVWAOXGIu0sAAX8ADNp4regAJ8hQk5kAO+eAsXwXw+QYzd4H4E1jQysIy2cAAs+BlvMguQuAw34HmX0AMxYP+NtXCBgDF9tkgOHVAC0xgJMUAy5EgLUmIL3bgMIAA+lDAz8SgLqqcXjrh1t6gMHSB7l5ADebWPr0AvEwGN3+ACgkQAEBmREqkpnmUIuISQsKAbFWBuDOkNYzKRIAmRJTBVGIkLP1ERbMgK9agNi9WKh7BTJakKasiCatgAg8GNAakNHJACKTCNr0hWMUkKcjOUKbkKK7kNHMBdZEYIrRWUh5ST3HAsNSiO8OiUpSB5dbKJr3CU3bABIYCPAFAA1WiVpeB7rtEKMdgQLVkINFADeZSAkRJ/P0CKZNkIPNGMUPkIadkQO5ACNzMIlSV/mCWX6FWXkXARC3ATRUl/edn/iTeQAp8YCRVmmJDwH3uxAIuZClwZDijgVpRZClOGfgtwea2wmeHglWD5mdLVmOGwjuDYNHSpmoIQEKunhgTRkfmAA97VjtiiAyIDlLLZjESJm/mwkz05CQogBJRSlbJJb6xJDp25lJDQA6wiBPNnleailZj3nOTAAyUQkuA5AxUJADQAMq6imkMpN5mpg9xJDisAKOAJkmJ2CMOimv3Aaf0whQrYnvTQl5CJCOwGnEG5kEdInBiCauOJWZNSKXXZggGALzcJkCcyMMdoCFiIV4IJAJNpjeY4mgaaIf4ZmYMgLF1GLNkVm4LYD/TIn/mAavFJABvQATV4os15CqZ5/xLvGZ/DFEwhAEjEtAI0WqOkcKMTIqN85FZBKqSEAH3SdwhVEhka6CMbwI5JuiwMUBIQ8I+TQH6AYQjVgZkRmocsOiHcxQFVKipGuHqW4H8AAIBUUhroKKZBcgOTeKZoQohyE6aSkIK64RiAoRXbOCflop89spOztaGEcoZpqBekaS26oYItUYd3GIWNQqiFWgKpOShXqglKCABM6KcecSpyKiSLxQNngqhpEn1ZaQluCIegARNuaIcLEKeGQKQisgIpUAIoYASFOSgKuZ6KgIgNoIhgIayNOhxj+iE40JlVMAVJMCgJ0A8G8B8fuiMcsAEpUAQoIJ1aIn44uSRSAP8FRZACL6opmdojqhoRwGoKtpoiFuAET1CuM/CVRKKQWrqVyVoidloIqDkk0doPeCihTbKvhNCvQvIcFBCw+/kkqFo49Aok1SERHvqtsWiwPrIAEWAAAqKn+KolChAEOag2D9sjixJyFAslMYNarfUCwGmxO8KCDxqB1XokNFBZMqBaJlewIUAA3Goj5vgAtFqa+RojPhAExAKTG3ADwfSjvAkj81gL7bojL/A0g8ABmeJHDjlgM4KVwKGdQmuNPaADOsCcgoADPHADIXADWvsivzqzaOJCvVi1SZu2a7siztIPx8qY+zi1P1Ayc/uN5VpMHjIXuBC1PxK2Y7sI1xr/uMSUIcCxF6t6svsIt5gAkRmSnmfJCnuJkTB5CZaLIdIaunkrCpurpInwuRmiidIxtKMalKMWf0CToQCQcoEbn304D/zwADXhGetaCoZLJK9LarF7WE2pXrULno2bD3i6Em5bl4eVCah7DzeRhsCBGs1LlmJ5WXHZW48Qvfhwgrfwu4MyarFbvI5Auy96u+ZAm7Z5m5JruovwvI/wkTr6musgnOp5vTUqv5rgvTEivrHIv9BLTLWrvp9FZeHLuoIowJhAv+WavN+wJgeQsPrbnAxsCv67DRPAABegEr07pAq8LGI5vAgYu9d5vvbrDRDgAAtSwbKZLSQMu5hlvpSQ/8HasBQTPLqaGcLOe5A1nMLcgC9iwQAK27HwGwoXHAk2vA0yoX7becRI3FoZGrzcWwhLjA0Q0MESwbFPDMWlJbyDyWU0PAhXfA3lRx6YwKQIfAj9ELSFAMBebAhJjL7HG7gGbIpFXAlcan4KUS9RGseskMQOXMf1Cw5s6qZe4scECMiscJGjUMbG9ah9iihquCiPyMOMTAqQTA18ujFZMQGiCoODismATMWyWwmbjAv/+rSU0KmfOpvpWYZ3McqZ3AqmDJeWkMq2gHWZSwmtGodfYYL9wBbWe8m1DA26XAsQGLmVIKzESgihvC+kfMyfkMy0oBaFO83UPAiOnMsEDP+Rd0wLqyetOmyj2rzNYenDlODAEMwLbfu+6NwK2QvG21vCYXxYQzAEU4yA2nvL2ssJqtq1LhzPnHDLMUzPr5vP+8zPB12ioMDK8EzQkQjEufCzbmyU5yzRm2DNrtAAaoEvtWjEGr0MHN0KJfvBowDHIy0KJc0KNqmxujvQK10LLb0KEQuB5cyuGT3TuUzRFR0AFCzTPC0LNU0OKj3UnVDUp4C/vbywSG0MSm0K7GubEujUT00MdGzHrwC+4CuwVz0Mg1yu4TwKRmiyXv3VKKGoaoiZaEnLaD0Vy2uImuvWbz0VqpvAdU0VDlDVQp3X6fCMeO3XJ5EVzGzVaCmtjKD/xnH6pNb3pPcq2GQ9nBGdCkM5sYiwx4UgmuQ3FOnH15AtCqsM0en4CnPzGIMxAaE7j4dMoC1REHPDhHHy2acg2obNCnNDKhYxnJ18flrxGQlhKpYs26Fg0X19CRKxFhm4fpK8MQ3SgkyhKP4QzcLtCR4dsyHdxa7gGgghCADRvgXhyp82CE5YAXABgL4y3XdTEmZd26swgKLcKAnxy6+qEXRoh4ghLdSC3qLw0gJy3V9L2uK2CM5cRhrBiOHRJvmi36Fw05bN3gouDwibx9j94PRwikE92RTeDrzc4KOd4fIgFhqLscXt4dkgjCh5CYptCM8BpX9M4u+wesChhiy+/6UZ0aWFMJSefQhH7eLFoJBNDQmrraVO4d6ty+PtENp4Swm7bQhuWCh0beRHDtQS/ghLvius/d6VutNQngsMntOHAN6BKggVsBReW6tavuW3gLEwzcVtWBquKoca0SAZARxTThtnjubKrN4orRAqMawEThlDKcs6fud4Pgswiy85/t+Fjg7EjeGLLg603eGPXg5qmM2Tfg7rPeKXvgzqqoaJrpKEvums8M5nLeomsuOmXgtKkbGBnereQBpyU+eg7urfQBdZih0rSuveYLKWKum6ng25Ldml/uvShbl7HgqoTuzpkOzKjumh3ux99ezQLg2lO+3JUe3WnlbZ7rjSvv/tnNzt3i4NzB7uuw7u5P4M437u0a7uf2Pu7L4M6f7uqynvOEXvdOXu9m4M8Z7v4o7v/D4M+/7v/Bh9a0wIjm0t/i7wo4DZBt/ZLa7w3xDkhADbW7HIEA8OVQ7dGm/MF4/xyw3NLiHdZt7x4ADmTbiQ543ljvIoY9jyLv/yMB/zMj/zNF/zNn/zgr4L8g3nAIDfpeHkUsjyNw+GMj70X1j0Rt+FSJ/08LL0TN8uTv/069LruzDgweypCW7xrZ7rlm58hB7wyFrroQ72du71ukD2FfH1Cc8JaJ/2Zt/1cM/1W7/ubz/3mu4JbZ/3a78Jbd8Val/3du/oIh1UY//3cS//94gPtXuvCX2v94Cf+HfP9oufCSqaC5V/C5dvC5mv+TkvC5svj51P8qI/+qRf+k+d4vHwpMUcD9Eq6+jApJOvxzXOx+9AL7TvDhcY+6pwga/BxGLRplfeDpRH3sHdDgOi+6ngHMf08fMAzO9AFxGB/KdAGh79+3DF/PHQqe9AGqc4ye6AF9yR3Nhg8vEQEf697Okp/aVAGhoBqdew8/HwGWqBE++A2kjBFK5fDiohIMUPCACCg4SFhoeIiYqLjIgMDQINDI2UlZaXmJmCApycAZqgoaKjhAECn6SpqquHCQ8CC5Oss7S1tre4ubq7vL2+v8DBwsPExcbHyMnKy8zN/87P0NHS09TV1tfY2drb3N3e3+Dh4uPk5ebn6Onq6+zt7u/w8fLz9PX29/j5+vv8/f7/AAMKHEiwoEFwBgxMEJRAIa4EEQ7IEhTgwIFDDi4mkHiwo0dfpi5WWLCgAq4GCwIYGMRAQARUhQ4IAGDg1MebOGtVgATBFAUAFSpGgCAo44ELCWgGSMBgJQWLDhYOSnDhgAOTLRvAnCDzwkoIEX8CkEnTJoCnQ5UmZfAp6ERBE1QCiKswAISMRHPqHQghkoAHgh6kfJVUq4MFDQCYWnDqggAHAR6shLvgQYDKABzAusgQ0gMGfSNodjB2Zs1PoyMIgJDgMQBICfqKHXS6rP/KSJEFJN3L+59M3QBaHwjg+JOBjIwVrxak+uVkQRSWa04qgPMgUytVmxRc2jYAzBVcvn7Q2rLmuJ0S2jxduy/M3vDz1eQ8P4B9A6EhvFI+ucKFV8tRJMBK2AFQXSEFktUdWbUdaOBFjjnwgIQPADZBQgZUUBt765kV34f2zDcISU1RwNYpEEDCnyAXUHCcALO1FoEBKG1inYBOoSgegzap1hOMAPQFY02uFdJaSjLd5hVhIDZJj4gMqRYJBBW80oCKBSrG2AKkEfLIX7s5eN2ARTEWgUk8tqUalyMCx9huhWjWQHE1QRKLk3jmuUxtevbpJzF8/inooIQWauihiCYlquiijDbq6KOQRirppJRWaumlmGaq6aacdurpp6CGKuqopD4TCAA7);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In the Diabetes Prevention Trial, insulin therapy did not prevent type 1 diabetes in siblings of diabetic patients with high serum islet-cell antibody concentrations and low acute insulin responses to glucose. Subjects received close observation or low-dose subcutaneous insulin (ultralente insulin administered twice daily; total daily dose 0.25 units/kg) plus annual four-day continuous insulin infusions. After median follow-up of 3.7 years, 69 of 169 subjects in the intervention group and 70 of 170 subjects (42 versus 41 percent, respectively) in the observation group were diagnosed with diabetes.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Diabetes Prevention Trial - Type&nbsp;1 Diabetes Study Group. Effects of insulin in relatives of patients with type 1 diabetes mellitus.&nbsp;N Engl J Med 2002; 346:1685.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_51_7998=[""].join("\n");
var outline_f7_51_7998=null;
var title_f7_51_7999="Anterior view of upper abdominal structures";
var content_f7_51_7999=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F62682&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F62682&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Anterior view of upper abdominal structures",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 207px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The spleen is located in the left upper quandrant of the abdomen beneath the left hemidiaphragm and lateral to the greater curvature of the stomach.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Bickley, LS, Szilagyl, P. Bates' Guide to Physical Examination and History Taking, 8th Ed. Philadelphia: Lippincott Williams &amp; Wilkins 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_51_7999=[""].join("\n");
var outline_f7_51_7999=null;
